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The memorandum from the Occupational Cancer Working 
Group 2013 is meant to update the suggestions made in the 
Memorandum from the Occupational Cancer Working Group 
from 1988. Its aim is to give recommendations regarding the 
diagnosis and compensation of occupational cancers.
In addition to the recommendations regarding the compensa-
tion of occupational cancers, the working group also takes a 
stand on the screening of lung cancer caused by exposure to 
asbestos, the forming of a special group of experts for occu-
pational cancer diagnostics, the combining of gathered expo-
sure information on asbestos, and the use of X-ray imaging 
determining the occurrence date for asbestosis.
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Memorandum from the Occupational Cancer Working Group 
ASSIGNMENT AND WORKING GROUP 
In a meeting on 13 April 2011, the Committee for Occupational Health of the Finnish 
Ministry of Social Affairs and Health proposed that the Finnish Institute of 
Occupational Health take action in order to review the suggestions made in the 
Memorandum from the Occupational Cancer Working Group from 1988. The Finnish 
Federation of Accident Insurance Institutions (TLV) delivered the memorandum as 
circular 6/89. The Committee justified the review, for example, by deviations that 
had occurred in compensation practices in cases of lung cancer caused by asbestos, 
even though it was generally acknowledged that the compensation practices from 
1988 were reasonably up-to-date and were still useful regarding asbestos. However, 
new information concerning other carcinogens proves that a current review of 
occupational cancers is in order. 
In a meeting on 15 June 2011, the Executive Committee of the Finnish Institute of 
Occupational Health set up a working group to review suggestions made by the 
Occupational Cancer Working Group of 1988 in cooperation with the Finnish Ministry 
of Social Affairs and Health (STM), the Finnish Federation of Accident Insurance 
Institutions (TVL), and medical experts from trade and industry unions. 
The members of the working group, which first met on 23 September 2011, include 
Kari Kurppa, Panu Oksa, Tiina Santonen, Jukka Uitti, and Henrik Wolff from the 
Finnish Institute of Occupational Health; Jaakko Hannula, Kristiina Mukala, and 
Heikki Savolainen from the Finnish Ministry of Social Affairs and Health; Mikael 
Hedenborg, Teemu Kastula, and Ilkka Torstila from the Finnish Federation of 
Accident Insurance Institutions (TVL); Kari Haring from the Central Organisation of 
Finnish Trade Unions (SAK) and Jan Schugk from the Confederation of Finnish 
Industries (EK). In its first meeting, the working group selected Ilkka Torstila as 
chairman. Teemu Kastula, Panu Oksa, and Tiina Santonen have, each in turn, acted 
as the secretary of the group. 
The working group convened 15 times and received expert opinions from Anssi 
Auvinen (occupational exposure to radiation), Timo Kauppinen (occupational 
exposure to carcinogenic substances), Eero Pukkala (epidemiology of cancer), Timo 
Tuomi (exposure to quartz and asbestos), Tapio Vehmas (imaging technologies), and 
Henrik Wolff (pathology of cancer). It also sent out a questionnaire on the 
assessment and compensation practices used in relation to occupational cancers to 
14 states of the European Union (EU). The results of this questionnaire are presented 
in a separate section of this memorandum. 
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The updated version of the memorandum adheres to the structure of the 1988 
memorandum. However, for example, the contemporary classifications of 
carcinogenic substances in the EU and references to managing the occupational risk 
factors related to cancer in EU legislation have been updated. 
The new practice for registering occupational accidents and diseases adopted in 2005 
and the related cost calculations are described in a separate section. 
Most of this memorandum consists of a review of carcinogenic substances according 
to exposure, complete with a literary overview (Section 5). Finally, the working group 
has made recommendations based on the review. In addition to the 
recommendations regarding the compensation of occupational cancers, the working 
group also takes a stand on the screening of lung cancer caused by exposure to 
asbestos, the forming of a special group of experts for occupational cancer 
diagnostics, the combining of gathered exposure information on asbestos, and the 
use of X-ray radiograph to determine the occurrence date for asbestosis. 
After having completed its assignment, the working group cordially presents this 
report to the Committee for Occupational Health of the Finnish Ministry of Social 
Affairs and Health. 
 
Helsinki, 30 May 2013 
 
Ilkka Torstila  Panu  Oksa   Tiina Santonen
  
 
Teemu Kastula Kari Kurppa  Jukka Uitti  
 
Henrik Wolff   Jaakko Hannula Kristiina Mukala  
 
Heikki Savolainen  Mikael Hedenborg Kari Haring  
 
Jan Schugk  
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ABBREVIATIO USED IN THE MEMORANDUM 
AB, asbestos body, coated asbestos fibre 
AF, attributable fraction 
ALL, acute lymphatic leukaemia 
AML, acute myeloid leukaemia 
ANLL, acute nonlymphocytic leukaemia 
ASA, a register of professionals exposed to carcinogenic substances and 
methods at work 
Bq, becquerel, unit of radiation activity 
CAS, Chemical Abstract Service, an American chemical substance 
identification system 
CCA, chromated copper arsenate, a wood preservative 
CI, confidence interval 
CLP, European Parliament and Council (2008) regulation on classification, 
labelling and packaging of substances and mixtures. Includes, for example, a 
classification system for carcinogens 
CT, computed tomography  
DNA, deoxyribonucleic acid 
EC, European Commission 
EMF, electromagnetic field 
EU, European Union 
FIOH, Finnish Institute of Occupational Health 
FROD, Finnish Register of Occupational Diseases 
HIV, human immunodeficiency virus  
HR, hazard ratio 
IARC, International Agency for Research on Cancer 
ICD-10, International Statistical Classification of Diseases and Related Health 
Problems, a medical classification list maintained by the World Health 
Organization (WHO) 
IRIS, Integrated Risk Information System 
MDS, myelodysplastic syndrome 
MELA, Finnish Farmers' Social Insurance Institution 
MOCA, methylenebis(2)-chloroaniline 
mSv, millisievert (see Sv) 
PAH, polycyclic aromatic hydrocarbons 
ppm, parts per million 
ppm-year, cumulative amount of exposure 
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OEL, occupational exposure limit 
OR, odds ratio 
PVC, polyvinyl chloride 
REACH, Regulation for the Registration, Evaluation, Authorisation and 
Restriction of Chemicals, a regulation passed by the European Union 
RR, risk ratio, rate ratio 
SCOEL, Scientific Committee on Occupational Exposure Limits, a committee 
of the European Union that issues expert statements on occupational exposure 
limits for chemicals in the workplace, founded in 1995 
SIR, standardised incidence ratio 
SMR, standardised mortality ratio 
Sv, sievert, unit of radiation exposure 
TAKO, Employment Accident Compensation Board 
TVL, Finnish Federation of Accident Insurance Institutions 
UV, ultraviolet 
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1 OCCUPATIONAL AND ENVIRONMENTAL 
CANCER 
1.1 Background 
Cancer is a multifactorial disease. It is also a common disease; about one in three Finns 
develops cancer during his or her lifetime. In the year 2009, for example, about 29 000 
new occurrences of cancer were diagnosed (Pukkala et al., 2011). During the last few 
decades, morbidity has increased because of the ageing of the population. 
Both human behaviour and environmental factors play a part in the origination of most 
cancers. There are few actual hereditary cancers, but genetic factors may modify the 
individual risk of developing cancer caused by environmental factors (Joensuu et al., 
2007). 
Cancer morbidity is somewhat higher for men than for women. According to statistics 
gathered by cancer associations, the morbidity of cancer among Finnish men has been 
about 300 for every 100 000 of the population. For women, the number is under 250 for 
every 100 000 (Pukkala et al., 2011). In Finland, there are also notable differences in the 
morbidity of cancer between different social groups (Pukkala and Weiderpass, 1999 & 
2002). Certain types of cancer have been shown to be related to a low socioeconomic 
status. These differences are, for the most part, caused by living habits and, for example, 
smoking (Pukkala, 2011). 
The risk factors for cancer can be divided into the following four classes (Pukkala et al., 
2011): 
• Biological or inherent risk factors, such as age, gender, the metabolism
of foreign substances, hereditary genetic defects and skin type; 
• Environmental risk factors, such as radon, ultraviolet radiation and small
particles; 
• Occupational risk factors, such as many chemicals, radioactive materials
and asbestos; 
• Risk factors caused by living habits.
Smoking is the biggest individual risk factor for one third of all cancers. The consumption 
of alcoholic beverages is also a significant risk factor, as it increases the risk of cancer of 
the mouth, pharynx, larynx, oesophagus, and liver (Baan et al., 2007). Nutrition affects, 
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for example, cancers of the intestines. In Western countries, obesity has also become a 
significant risk factor for cancer. In a recent estimate published in Great Britain, obesity 
was the second most significant risk factor for cancer among women after smoking, 
whereas, among men, unhealthy eating habits (limited use of fruit and vegetables), 
occupational risk factors, and the consumption of alcohol were emphasised (Parkin et al., 
2011). Sexually transmitted infections (especially HPV, human papilloma virus) are also 
well-known risk factors for cancer. Some nutritional factors and physical activity seem to 
have a protective effect against certain types of cancer (www.dietandcancerreport.org). Of 
the environmental risk factors, radon in room air causes about 10% of the lung cancers 
diagnosed in Finland. 
Certain professions have been found to be associated with an elevated risk of cancer. The 
differences in morbidity between various professions have been studied in the broad 
Nordic NOCCA research project (Nordic Occupational Cancer, 
http://astra.cancer.fi/NOCCA). The research found significant occupational differences in 
the morbidity of several types of cancer. Some of these differences are easily identifiable 
and are connected with risk factors that have been already noted for certain professions. 
These include, for example, lung cancer and mesothelioma among plumbers (caused by 
exposure to asbestos), the risk of lung cancer among miners (caused by exposure to 
quartz and radon), cancer of the nose among sawmill workers (caused by exposure to 
wood dust), and lip cancer among fishermen (caused by exposure to ultraviolet radiation). 
Some differences are not necessarily related to occupational exposures as such, but 
primarily to differences in living habits (especially smoking, alcohol consumption) between 
professions. For some deviations, however, there is currently no viable explanation. 
 
1.2 Occupational cancer 
 
The number of occupational cancers or their percentage of all cases of cancer is not 
exactly known, but estimates can be made on the basis of epidemiological studies. At 
one time, Doll and Peto (1981) estimated the proportion of occupational cancers in 
the United States to be about 4% of all cancers (variation 2%–8%). From the studies 
carried out in Finland, Aitio & Kauppinen (1992) estimated that, in the early 1990s, 
work was the cause of about 500 cases of cancer annually (2%–3% of all cancers). 
In addition, according to a Nordic estimate, about 2% of all cancers occurring in 
Finland in 2000 would have been caused by occupational risk factors (Dreyer et al., 
1997). For men, the estimate was 3% of all cancers, whereas, for women, the 
proportion was less than 0.1% (Dreyer et al., 1997). In turn, Nurminen and 
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Karjalainen (2001) estimated that the attributable fraction of occupational risk 
factors was 8% for deaths caused by malignant tumours. Similar estimates have 
been made also in other countries, for example, Great Britain (Ruston et al., 2010). 
The variation between different estimates can be explained by methodology, 
including, for example, the quality of data and exposure. In addition, these kinds of 
estimates include a great deal of uncertainty, related, for example, to the accuracy of 
the assessment of exposure levels and the type of epidemiological data on which the 
estimate is based. 
As the exposure levels decrease, the number of occupational cancers will also 
decrease. Whereas Nurminen and Karjalainen (2001) used epidemiological risk 
relationships to estimate that, at the end of the 1990’s, 85–273 deaths from lung 
cancer and 56 deaths from mesothelioma were caused by asbestos, Priha et al. 
(2010) estimated that the current levels of occupational exposure to asbestos will 
cause about one asbestos cancer (lung cancer or mesothelioma) per year in the 
future. 
It must be noted that the aforementioned assessments describe the percentage of 
occupational risk factors from total cancer morbidity and that they also include cases 
in which profession is only one factor contributing to cancer. Only diseases for which 
occupational exposure is the primary cause can be classified as occupational 
diseases. Therefore, the assessed numbers of occupational cancers will not be 
reflected in the compensation system. It is also very difficult associate lung cancer 
and many other cancers with occupational risk factors. Cancer may manifest itself 
only after the person has retired, and therefore its relationship to the person’s 
profession is not discovered. In case the person is, or has previously been, a smoker, 
it may be difficult to prove the occupational nature of the cancer, and also 
occupational cancer can be attributed to smoking. These factors may lead to 
occupational cases of cancer being underdiagnosed. 
Today, lung cancer and mesothelioma caused by exposure to asbestos are definitely 
the most important types of diagnosed occupational cancers. Between 1996 and 
2009, physicians reported about 1400 cases of cancer to the Finnish Occupational 
Disease Register (FROD) maintained by the Finnish Institute of Occupational Health 
(FIOH). Of these cases, 1349 were caused by exposure to asbestos, and 6 by 
exposure to quartz. The other cases were caused by other isolated exposures. These 
figures cannot, however, be taken as an indication that such cases do not exist. 
There is also some underdiagnosis involved. 
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1.3 Research on cancer risk 
The risk of cancer associated with different types of exposure can be studied with 
either experimental or epidemiological methods. Because the objectives are to 
identify the types of exposure that increase the risk of cancer and to prevent 
exposure to them, certain experimental methods (animal testing and cell culture 
tests) have been developed to identify carcinogenic effects in advance. 
Data acquired using animal testing and cell-culture tests do not always predict an 
increased risk of cancer among humans. If the exposure has been in general use, the 
increased risk to humans can be studied using epidemiological methods (population 
research). 
1.3.1 Experimental studies 
The available information on the carcinogenic effects of chemicals or chemical 
mixtures available today is primarily based on animal testing. The standard method 
used for testing carcinogenic properties was developed in a 2-year cancer study 
carried out on rodents. Certain factors may decrease the importance of results 
acquired by animal testing when the risk of cancer among humans is being assessed. 
These factors can include, for example, noted differences in the metabolism of 
humans and test animals or mechanisms of actions, which are known to be less 
important for humans. 
Although a carcinogenic effect detected in an animal test would be considered to be 
probably significant for humans, it cannot be definitely stated that the exposure 
would cause similar cancers in humans as it did in the test on animals. The same 
substance may cause cancer in very different ways in different species, and, for 
example, the exposure route affects the probability of each type of cancer. In 
addition, there is possibly a variation between species with respect to their sensitivity 
to certain types of cancer. Therefore, it is impossible to evaluate the probability of 
occupational cancer based on animal testing. However, from the point of view of risk 
management, the carcinogens found in animal testing must be taken as seriously as 
those revealed by data on humans. 
The use of genotoxicity tests in the assessment of carcinogenic properties is based 
on the fact that the transformation of a normal cell into a cancer cell is known to 
occur through genetic mutation. Therefore, a substance that causes mutation is also 
potentially carcinogenic. Risk of cancer may, however, also be caused by a non-
genotoxic method. Therefore, the fact that a substance is not genotoxic does not 
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mean that it cannot be carcinogenic. In addition to genotoxicity tests, the potential 
carcinogenic properties of chemicals can be preliminarily assessed using structure-
activity relationships. The attitude towards substances whose genotoxic effects are 
strongly evident must be similar to those whose carcinogenic effects have been 
noted in animal testing. The probability of an occupational cancer occurring in an 
exposed group of people cannot, however, be estimated on the basis of genotoxicity 
tests or structure-activity relationships. 
1.3.2 Epidemiological research 
Epidemiological research can be used to demonstrate an increased risk of different 
cancers among an exposed group of people. These studies provide information about 
the dose–response relationships with respect to humans, as well as the types of 
cancer that are typical for each exposure. It must be noted, however, that 
epidemiological research cannot accurately indicate small increases in risk. Therefore, 
negative epidemiological studies cannot usually be used to completely rule out a risk, 
even though they may inspire confidence in the insignificance of the risk.  
Like other epidemiological studies, also those related to cancer can be carried out 
either as case-control studies or cohort studies. The long latency of cancer is one of 
the most important factors that makes the epidemiological study of cancer difficult. 
The latency period may vary from 5 to 50 years according to the level of exposure 
and the type of cancer. During this period employees have time to, for example, 
change jobs, making tracing the exposure difficult, and also expose themselves to 
other factors, which obscures the results of the study. An extended latency period 
also creates problems with the estimation of the exposure level since these estimates 
must be made retrospectively over several years or even decades. 
1.3.2.1 Epidemiological concepts 
Risk ratio 
Epidemiological research creates such statistical indicators as the risk ratio (RR), 
which illustrates the affiliation between exposure and morbidity. If the RR equals 1.0, 
the exposure does not increase or decrease morbidity. If the RR is greater than 1.0, 
the exposure increases morbidity, and, if it is less than 1.0, the exposure decreases 
morbidity. If the results of the research indicate that RR equals 2, the exposure 
increases the morbidity twofold. Other epidemiological indicators include the 
standardised incidence ratio (SIR) and the standardised mortality ratio (SMR), which 
compare the risk of morbidity and mortality, respectively, to those of the entire 
population. Another indicator is the odds ratio (OR), which is used for measuring, for 
example, the effect of exposure (“risk”) in case-control studies. 
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Attributable fraction 
The attributable fraction (AF) of exposure refers to the portion of morbidity that 
would not exist without exposure.  
Relationship between the attributable fraction and the risk ratio 
The formula AF=(RR–1)/RR is a reduced description of the calculated relationship 
between the attributable fraction and the risk ratio.  
If the RR of a group of employees with a certain exposure level is 2.0 when the 
group is compared with a group of unexposed employees, the calculated AF of the 
morbidity caused by the exposure is 50%. In other words, of those among the 
exposed group that have cancer, 50% have cancer due to the exposure in question, 
and 50% have developed it for some other reason. 
If the RR is 3.0, there is a calculated 67% probability that the exposure in question is 
the cause of the disease in question. If the RR is 5.0, there is a calculated 80% 
probability that the exposure in question is the cause of the disease in question. If 
the RR is 10, there is a calculated 90% probability that the exposure in question is 
the cause of the disease in question. 
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1.3.2.2 Occupational cancer is a diagnosis based on probability
When it comes to the course of a disease or its pathological properties, occupational
cancer does not differ from other similar cancers. There is no medical test that would
indicate that occupational cancer is caused by work. According to occupational
disease legislation, the relationship between a type of exposure and a certain disease
must be strong enough to identify exposure as the probable cause of the disease.
An occupational disease diagnosis of an individual employee who has developed
cancer must be based on probabilities. The probabilities are derived from the results
of epidemiological studies (i.e. scientific appraisal of population experience). If the
employee’s exposure level is high enough to increase the group-level cancer
morbidity more than twofold in comparison with that of the groups of unexposed
employees, the cause of cancer is considred probably occupational in individual
compensation judgments.
Risk of cancer in relation to exposure
The results of epidemiological research usually provide a basis for the recognition of
occupational cancer.
As a diagnostic criterion for occupational cancer, it does not suffice that the employee
with cancer has been exposed to a substance known to cause cancer (for instance, to
ionising radiation, asbestos, or quartz). The exposure must have been high enough
to increase the group-level morbidity of the exposed employees by over twofold in
comparison with that of an unexposed group (RR > 2). An epidemiological risk ratio
of 2.0 is the theoretical milestone for a 50% probability of causation. In such cases, it
can be calculated that every other case of cancer in the exposed group has been
caused by exposure.
If the criteria for the exposure classification in an epidemiological study are loose (for
example, profession only), and the analysis does not separate a risk for the exposed
people according to categories of exposure intensity, the aggregate result may
indicate only a slightly elevated risk ratio (RR < 2). Such a result can lead to an erro-
neous interpretation, according to which the aggregate RR < 2 would apply to all
employees of all exposure levels.
Therefore, in informative epidemiological research, exposed employees need to be
classified into groups according to their exposure level. Each group classified by the
intensity of exposure has its individual level of risk for cancer morbidity. An
aggregated epidemiological result does not apply to all of the groups of exposed
employees. For the group with the highest exposure, the RR may well be > 2 even
though the average RR defined according to all of the research data is < 2.0.
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A major part of occupational cancer morbidity cannot be individualised 
Occupational cancer morbidity is an entity consisting of both cancer cases that can 
be recognized as an occupational disease and those that are partly caused by work 
but are not recognized as an occupational disease. 
Only cases for which exposure increases the morbidity to over twofold (RR > 2.0) 
can be recognized as occupational cancers. Occupational cancers that are not 
recognized are cases in which the individual intensity of exposure is not high enough 
for a probability diagnosis, and therefore they cannot be found in occupational 
disease statistics. Many types of carcinogenic agents related to work are known as 
weak carcinogens (group level RR < 2.0). Using epidemiological methods it is 
possible to evaluate the percentage of cancers cause by occupational exposure from 
total cancer morbidity. 
When the causal relations between occupational exposure and cancer morbidity is 
evaluated, three context levels can be identified. 
Context levels of the evaluation of causal relations: 
1. Individual epidemiological study
2. Scientific generalisation (available evidence, systematic
review)
3. Cause of disease of an individual employee
Scientific generalisation 
? consistency 
o reproducibility
Individual epidemiological study
When the results of an epidemiological study are being evaluated, the following
factors should be taken into account:
x systematic error (bias)
x confounding
x random error
x strength of association
x internal consistency (exposure-response relationship,
subgroup results)
x chronological association
x biological credibility
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o strength of association (including statistical meta-
analysis) 
? biological consistency (coherence) 
? effect of intervention 
1.4.1 Classification of chemicals in the European Union 
In 2009, Regulation (EC) No. 1272/2008 of the European Parliament and of the Council on 
the classification, labelling and, packaging of substances and mixtures (CLP regulation) 
came into force in the European Union (EU). This regulation was based on the United 
Nations Globally Harmonised System (GHS) of classification and the labelling of chemicals. 
In individual cases, the basic prerequisite for evaluating causal relations is that the
exposure (quality, level, temporal connection) has been assessed as being high
enough to have been able to cause the disease.
Cause of disease of an individual employee
Scientific data approved by the scientific community are used when the probability of
occupational cancers of individual employees are being evaluated.
1.3.2.3 Systematic and random error in epidemiology
In epidemiology, errors in results can be caused by systematic error (bias) or ran-
dom error. Random error can be decreased by increasing the size of the research 
group, and its magnitude can be characterized using statistical significance or 
confid-ence intervals. Hidden systematic error is more serious and problematic 
be-cause it cannot be removed by increasing the size of the research group, and 
it can-not be corrected or evaluated using statistical methods.
When the risk ratio is low or moderate (RR < 2), the interpretation of epidemiological 
results is often problematic and distorted by bias mechanisms. Confidence intervals 
and statistical significance characterize statistical uncertainty (stochastic 
effect), but they do not measure the distortion caused by systematic error 
and epistemic uncertainty, whose dimensions are usually much more 
significant than statistical uncertainty. The lower the risk ratios, the more 
difficult errors and distortions in epidemiology are to detect.
1.4  Scientific and administrative classification of
cancer risk
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According to the regulation, chemical substances that induce cancer or increase its 
incidence are assigned to one of two hazard categories (1 and 2). The substances must be 
labelled with appropriate hazard statements and symbols. Category 1 has two 
subcategories (A and B). Carcinogenic substances are allocated to one of two categories 
based on the strength of evidence and additional considerations (weight of evidence). In 
certain instances, exposure route-specific classification may be warranted if it can be 
conclusively proved that no other route of exposure can cause the hazard. The latter may 
apply, for example, if the carcinogenicity of a substance is known to be related only to 
inhalation exposure. 
Hazard categories for carcinogens in Regulation (EC) 1272/2008: 
Category 1: Known or presumed human carcinogens 
? A substance is classified into Category 1 for carcinogenicity on 
the basis of epidemiological and/or animal data. 
Category 1 is further divided into 
? Category 1A for substances known to have carcinogenic 
potential in humans, the classification is primarily based on 
human evidence. 
? Category 1B for substances presumed to have a carcinogenic 
potential in humans; the classification is primarily based on 
animal evidence. 
Category 2: Suspected human carcinogens 
? A substance is placed in Category 2 on the basis of evidence 
obtained from human and/or animal studies, but which is not 
sufficiently convincing for placement in Category 1A or 1B, on 
the basis of the strength of the evidence together with 
additional considerations. 
The classification of a substance into Category 1 affects its use, for example, in 
consumer products. These are also the primary substances when the need for 
specific prohibitions and regulations on the use of substances in the EU are 
considered. 
1.4.2 IARC classification 
The aforementioned EU classification of substances and mixtures is somewhat different 
from the classification used by the International Agency for Research on Cancer (IARC), 
which divides estimated exposure into the following four groups: 
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Group 1 substances that are carcinogenic in humans 
Group 2A substances that are probably carcinogenic in humans 
Group 2B substances that are possibly carcinogenic in humans 
Group 3 substances that are not classifiable as to their 
carcinogenicity in humans 
Group 4 substances that are probably not carcinogenic in humans. 
In addition to chemicals, IARC has also classified many medicinal substances (for 
example, antineoplastic agents and hormonal preparations), as well as physical and 
biological factors that increase or are suspected to increase the risk of cancer. IARC 
has also classified some events of exposure, such as work conditions, that increase 
the morbidity of cancer. The IARC lists of substances that are carcinogenic in 
humans, probably carcinogenic in humans, and possibly carcinogenic in humans can 
be found on the website of the organization at http://monographs.iarc.fr/. 
1.4.3 List of carcinogenic substances and ASA 
In Finland, carcinogenic substances are also classified by the Finnish Ministry of 
Employment and the Economy resolution (TMp 1060/83 and its updates, see 
appendices). This is a list of exposures that must be reported to the register of 
workers exposed to carcinogenic substances and processes (ASA register). The 
substances in this list differ somewhat from those classified as carcinogens, for 
example, by the EU. 
 
1.5  EU legislation related to the management of cancer
risk in the workplace
In relation to carcinogens or mutagens found at work, the EU has issued Directive
2004/37/EC, which emphasises minimising exposure to carcinogens or mutagens at work,
informing employees, and monitoring exposure and employee health. Occupational cases
of cancer must be reported to the authorities.
The chemical regulation of the EU [REACH Regulation (EC) No 1907/2006] requires a
safety assessment of all widely used chemicals, including carcinogens. The problem with
chemicals has been that only some of the widely used ones have been tested and properly
evaluated in relation to their carcinogenicity. REACH responds to this deficiency by
establishing procedures for collecting and assessing information on the properties and
hazards of substances, for defining exposure limits and managing risks related to
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substances in different uses. REACH includes mechanisms for restricting, and even 
prohibiting, the use of the most hazardous, for example, carcinogenic, substances. The 
REACH regulation does not, however, cover all of the chemical exposures related to 
occupational cancers, for example, quartz. 
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2 CURRENT COMPENSATION PRACTICES AND 
PROBLEMS RELATED TO COMPENSATION 
2.1 Legislation and guidelines 
The Finnish requirements governing the obligation to report occupational diseases or other 
work-related diseases within health care are regulated by the Act on Occupational Safety 
and Health Enforcement and Cooperation on Occupational Safety and Health at 
Workplaces (44/2006). Section 46 of the Act (1564/2009) states that, if a physician has 
good reason to suspect an occupational disease or other work-related disease, he or she 
must immediately report it to the Regional State Administrative Agency, notwithstanding 
the confidentiality regulations. The report must include the following information: 
? Name, personal identification number and other contact 
information of the person taken ill 
? Name and contact information of the employer 
? Other relevant contact information 
? Type and duration of exposure 
? Information about the type and detection of the disease, as 
well as its harmful effects. 
The Regional State Administrative Agency must, according to Section 46, deliver 
information received from reports to the Finnish Institute of Occupational Health 
(FIOH) for entry into its Finnish Register of Occupational Diseases (FROD). 
Some of the work-related diseases fulfil the criteria for occupational diseases that are 
to receive compensation from accident insurance institutions. These criteria are 
defined in the Act on Occupational Diseases (29.12.1988/1343) and its Decree on 
Occupational Diseases (29.12.1988/1347). 
According to the Act on Occupational Diseases, an occupational disease that is to be 
recognised by an accident insurance institution is a disease that has probably 
primarily been caused by physical, chemical, or biological factors in the workplace. 
The Decree on Occupational Diseases contains a list of the commonest occupational 
diseases and exposures that can cause them. 
This list of occupational diseases is not complete or restrictive. A disease not on the 
list can be recognised as an occupational disease if causation between the disease 
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and physical, chemical, or biological exposure factors can be identified with 
reasonable probability. 
Both the Finnish Federation of Accident Insurance Institutions (TVL) and the connected 
Employment Accident Compensation Board (TAKO) have issued specifications for 
occupational diseases to insurance institutions. An essential specification was the 
Employment Accident Compensation Board circular 2/2010 about the handling of 
occupational diseases. The purpose of this circular is to ensure that all cases of 
occupational disease are processed uniformly and quickly, to secure the legal 
protection of the insured during the entire process, and to instruct insurance 
institutions to avoid the transferral of cases from one institution to another. The 
circular contains, for example, directions related to the manifestation dates for the 
commonest occupational diseases and the definition of the insurance institution 
responsible for compensation. To promote the processing of occupational disease 
cases, sample questions for insurance institutions have also been included in the 
circular to be used as templates when necessary information is being acquired. 
Forensic investigation of causes of death has a significant influence on the 
determination of severe cases of an occupational disease. According to the Section 7 
of the Act on Determining Cause of Death (1.6.1973/459), the police must conduct 
an investigation, for example, when the cause of death has been an occupational 
disease or when there is reason to suspect such a cause. According to Section 9 of 
the Act, a forensic autopsy must be performed if the cause of death cannot be 
determined on the basis of the medical certificate issued by the physician who 
performed an external inspection or other information revealed by the investigation. 
In other words, forensic autopsy is not required to determine the cause of death in 
occupational disease cases if the attending physician is able to define the cause of 
death as being an occupational disease that has enabled the patient to receive 
compensation during his or her lifetime. 
It must be noted, however, that compensation paid for occupational diseases is 
dependent on the practices and agreements of the insurance system, and the 
decisions of the insurance system are not directly related to the results determining 
the cause of death. Since the provincial governments were abolished, the National 
Institute for Health and Welfare has been the authority with jurisdiction over forensic 
investigations of the causes of death in Finland. It has been in charge of forensic 
autopsies ordered by the police since 1 January 2010. As a result of the activities of a 
working group nominated by the Finnish Ministry of Social Affairs and Health, coroners 
have received guidelines about determining occupational diseases caused by 
asbestos (handout 23 February 2011, Occupational Disease in Forensic 
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Investigations for Cause of Death and Practices for Dispensing Compensation for 
Occupational Diseases, Working Group’s Final Report 20 March 2012). 
There are no special rules for the compensation of cancer as an occupational disease. 
The specific criteria used when a case of cancer is recognised as an occupational 
disease as defined in the Act on Occupational Diseases are mainly based on the 
report of the Occupational Cancer Working Group from 1988. In accordance with the 
assignment given to the Working Group, which was nominated by the Finnish 
Federation of Accident Insurance Institutions (TVL), the report concentrated primarily on 
cancers caused by exposure to asbestos. The report also defined a generic approach when 
identifying exposure in cases of cancer. The report of the Working Group was delivered to 
insurance institutions on 25 January 1989 as circular 6/89 of the Finnish Federation of 
Accident Insurance Institutions (TVL). 
2.2 Compensation practices 
When compensation for cancer cases is being assessed, the same principles apply as 
with other occupational diseases. Proving an occupational disease postulates that: 
? A disease that may have been caused by exposure has been detected, 
? Exposure can be proven to be work-related, and the quality and level of 
exposure has been determined, 
? Medical differential diagnostics rule out the probability of the disease being 
caused by some other factor. 
The biggest challenge related to compensation for occupational cancer involves 
proving the individual cause-effect relationship. Although there is much 
epidemiological evidence on the relationships between, for example, exposure to 
asbestos and lung cancer and malignant mesothelioma, it is not possible to 
determine a single reason for these or any other cancers in individual cases with the 
use of current medical information. Many cancers related to occupational exposure, 
such as lung cancer and bladder cancer, are also known to be increased significantly 
by smoking. Therefore, identifying cause and effect in individual cases is even more 
difficult. 
The relationship between exposure to asbestos and lung cancer was suspected 
already in the 1960’s, but, at that time, the causation was not considered to be 
proven scientifically beyond dispute. In 1961, the first case of lung cancer suspected 
to have been caused by exposure to asbestos was processed in Finland. In this case, 
the causation between asbestos exposure and lung cancer could not, however, be 
shown, and the insured employee was denied occupational disease compensation in 
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different courts. When the relation between exposure to asbestos and lung cancer 
was later scientifically proven, the Supreme Court overturned its earlier ruling based 
on additional evidence, and the matter was returned to Insurance Court. In 1972, 
the Insurance Court ruled that occupational disease compensation was to be paid in 
this case. Even before this ruling, insurance institutions had adopted the practice of 
treating lung cancer among patients suffering from asbestosis as an occupational 
disease and offered compensation accordingly. It had also become the general 
practice to offer compensation to lung cancer patients with asbestosis regardless of 
whether the insured had previously been a smoker or not. 
The compensation practices regarding mesothelioma were settled by Insurance Court 
rulings. In these rulings, a relatively short period of exposure to asbestos was 
considered to be enough to validate compensation for mesothelioma. For example, in 
one case of mesothelioma that received compensation, the task of dismantling and 
building an oven in a period that lasted only one week in one year was considered 
sufficient exposure to asbestos. 
The compensation practice regarding cancers caused by exposure to asbestos has 
been settled according to the guidelines given by case law and the 1988 report of the 
Occupational Cancer Working Group. A well-established practice regarding lung 
cancers caused by exposure to asbestos has been to offer compensation for lung 
cancer as an occupational disease if the patient has been diagnosed as having 
asbestosis. In addition, lung cancer has received compensation as an occupational 
disease caused by asbestos if the patient’s work history contains levels of exposure 
that may increase the risk of cancer twofold. A patient’s history of smoking is not 
taken into account when the decisions are made. Instead, compensation is based on 
the assessment of the level of exposure to asbestos. Cancer patients may therefore 
also receive compensation in situations in which asbestosis has not been diagnosed. 
In these cases, sufficient evidence of the level of exposure (work history, 
bronchoalveolar lavage or tissue samples, other diagnosed diseases related to 
asbestos, etc.) is required. The latency period applied for lung cancer is 10 years. 
Malignant mesothelioma of the pleura or peritoneum receive compensation as an 
occupational disease caused by asbestos if the patient’s work history contains some 
exposure and if the latency period is at least 10 years. Smoking is not taken into 
account when decisions concerning compensation for mesothelioma are made. 
If the level of exposure to asbestos seems uncertain in relation to lung cancer, the 
compensation for the cancer as an occupational disease must be decided according 
to special measures in individual cases. In borderline or otherwise difficult cases, 
insurance institutions have developed the practice of requesting a statement from 
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pneumoconiosis specialist groups at university hospitals or, especially, from the 
Pneumoconiosis Specialist Group at the Finnish Institute of Occupational Health 
(FIOH). 
Decisions concerning other cancers caused by asbestos have been made according to 
individual deliberation, and general compensation recommendations cannot be made 
because of the small number of cases. 
Individual deliberation is also required in cases in which some exposure other than 
asbestos is suspected to have caused cancer. The annual number of such cases in 
the insurance system has been too low for compensation practices to have been 
formed. A compensation practice has been agreed upon mainly for lung cancer 
patients with silicosis.  
A recognised occupational disease entitles a patient to compensation, for example, 
for loss of income, treatment, medical and occupational rehabilitation, aid, and 
permanent handicap. In fatalities, funeral expenses and a possible family pension are 
furnished. 
The compensation practice for cancers related to asbestos exposure differs from the 
practice related to other occupational diseases essentially only by the definition of 
permanent handicap. As the prognosis of lung cancer and mesothelioma is still poor 
and because they usually advance rapidly and quickly lead to death, compensation 
for permanent handicap has been agreed upon. A handicap allowance for handicap 
class 10 is therefore always paid on the anniversary of the diagnosis of lung cancer 
or mesothelioma. This is also the case in situations in which the status description 
would not yet entitle compensation for a permanent handicap at such a level. For 
compensation, the manifestation date of lung cancer in relation to asbestosis is 
considered to be the same as the manifestation date of asbestosis. In such cases, 
handicap class 10 usually receives compensation as soon as the cancer has been 
diagnosed. 
When cancer advances in a way that indicates a poor prognosis (e.g., disease 
advancing despite treatment, occurrence of metastasis, rapid deterioration of the 
general state of the patient), compensation corresponding to handicap level 20 is 
paid continuously as an annuity. A handicap allowance of level 20 is also paid if the 
disease has advanced in the aforementioned manner already on the anniversary of 
its manifestation. This procedure is implemented to account for a handicap in a 
rapidly changing and deteriorating situation. A similar handicap compensation 
practice has been applied to occupational cancers whose prognosis is considered 
poor, as with lung cancer or mesothelioma. 
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Despite the fact that the exposure may have ended decades earlier and the person 
with occupational cancer has been, for example, retired for several years, he or she 
is entitled to occupational disease benefits as defined in the Employment Accident 
Insurance Act. If the accident pension is the primary compensation of the patient, it 
must be determined whether the employee with occupational cancer would be fit for 
his or her previous occupation. In other words, in most cases, an occupational cancer 
leads to the granting of an accident pension. 
2.3 Statistics 
2.3.1 Register of occupational accidents and diseases 
 
Annually, about 25 000–30 000 Finns develop cancer. The number of occupational 
cancer cases or the total of costs caused by cancer is not exactly known, but the 
extent of the effect on the insurance system and its expenditures as a result can be 
studied, for example, from the registers maintained by the Finnish Federation of 
Accident Insurance Institutions (TLV). 
One of the tasks of the TLV is to maintain a register of occupational accidents and 
diseases as defined by Section 64 (723/2002) in the Employment Accident Insurance 
Act. The TLV register contains, for example, case-specific information about all 
registered cases of occupational disease and their compensation. Information about 
whether an illness has been recognised as an occupational disease has been 
systematically entered into its register since 2005. 
According to the TLV register, about 6000–7000 new or suspected cases of 
occupational disease have been processed every year according to the statutory 
accident insurance system in the beginning of the 21st century. The number of new 
or suspected cases of occupational disease has declined significantly during the last 
few years. Whereas in 2005, more than 7000 new or suspected cases of occupational 
disease were registered, the number had declined to about 6000 per year by 2010. 
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Table 1. Total number of new or suspected cases of occupational disease by the year of 
registration, 2005–2010. 
 
Year of registration 
New and suspected 
cases of 
occupational 
disease 
2005 7040 
2006 7188 
2007 6325 
2008 6263 
2009 6188 
2010 6006 
 
The information in this table is based on the combined register of occupational diseases maintained by 
the Finnish Federation of Accident Insurance Institutions (TLV), which contains all employees and 
entrepreneurs, as well as all insurance institutions. 
 
The number of cancer cases receiving compensation as an occupational disease 
varied between 140 and 170 in 2005–2010. Whereas the total number of new cases 
of occupational disease has been declining in the last few years, similar development 
has not occurred for cancers. In 2010, a total of 166 cases of cancer recognised as 
an occupational disease were registered by the insurance system. 
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Table 2. Cases of cancer recognised as an occupational disease by the year of registration, 
2005–2010. 
 
 
Year of registration 
 
 
 
Registered cases 
of cancer 
2005 155 
2006 144 
2007 153 
2008 171 
2009 157 
2010 166 
 
The information in this table is based on the combined register of occupational diseases maintained by 
the Finnish Federation of Accident Insurance Institutions (TLV), which contains all employees and 
entrepreneurs, as well as all insurance institutions. The cases of cancer correspond to codes C00-D48 
of the ICD-10 classification and codes 140-239 of the IDC-09 classification. 
 
An insured person receives compensation for medical expenses and loss of income as 
a result of an occupational disease from the statutory accident insurance system. In 
addition to medical and certain other expenses, for example, a daily allowance and 
an accident pension for the loss of income, as well as handicap compensation paid in 
compensation for a permanent handicap caused by an accidental injury or 
occupational disease. Moreover, in cases of fatality, a family pension is paid to 
children and the widow or widower, as well as funeral compensation to the estate. 
In cancer cases, the commonest forms of compensation paid by the statutory 
insurance system are pensions and other permanent compensations, such as 
handicap compensation in cases of permanent handicaps. The number of long-term 
compensation agreements has increased significantly during the last few years. Table 
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3 presents the amount of insurance compensation (without indexation) paid because 
of cancers by the type of compensation, as well as the number of cases receiving 
compensation in 2007–2011.  
 
Table 3. Amounts (without indexation) paid by accident insurance because of cancer by 
type of compensation and number of compensated cases in 2007–2011. 
 
Year of 
payment 
Compensation for 
expenses in euros 
(cases) 
Daily allowance in 
euros (cases) 
Pensions and 
other permanent 
forms of 
compensation in 
euros (cases) 
Total in euros 
(cases) 
2007 1 197 514 (240) 1 784 231 (103) 10 240 254 (780) 13 221 999 (1123) 
2008 1 191 548 (268) 1 617 195 (91) 11 041 451 (815) 13 850 194 (1174) 
2009 1 529 989 (244) 1 703 292 (98) 12 024 517 (858) 15 257 798 (1200) 
2010 1 355 234 (247) 2 000 231 (105) 12 743 696 (879) 16 099 161 (1231) 
2011 1 768 159 (238) 1 738 819 (84) 13 106 395 (908) 16 613 373 (1230) 
Total 7 042 444 (1237) 8 843 768 (481) 59 156 313 (4240) 75 042 525 (5958) 
 
The information in this table is based on the combined register of occupational disease maintained by 
the Finnish Federation of Accident Insurance Institutions (TLV), which contains all employees and 
entrepreneurs, as well as all insurance institutions. The cases of cancer correspond to codes C00-D48 
of the ICD-10 classification and codes 140-239 of the IDC-09 classification. 
Compensation covers the costs of, for example, physicians’ fees, medications (excluding free 
medication), hospital fees, and research expenses. Daily allowances include both a 4-week allowance 
and what is called an annual income allowance. Permanent compensation covers accident pensions, 
funeral compensation, family pensions, rehabilitation expenses, and handicap compensation, as well 
as handicap, garment and guide dog supplements. 
If several types of compensation (e.g., the compensation of expenses and daily allowances) have 
been paid for the same incident in a given year, the incident is shown in both columns.  
The euro amounts have been rounded to even values.  
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2.3.2 Finnish Register of Occupational Diseases 
In addition to being registered by the Finnish Federation of Accident Insurance 
Institutions (TLV), occupational diseases are registered, and the register is published, by 
the Finnish Institute of Occupational Health (FIOH). The Finnish Register of Occupational 
Diseases (i.e., FROD) is a research register that is used in occupational health research 
and the prevention of occupational diseases. Since FIOH is not a statistical authority, the 
occupational disease publication FROD is not an official statistical record. Official statistics 
on occupational accidents and diseases are maintained by TLV. 
Since 1964, FROD has been used to gather information on patients who undergo a 
medical examination for a recognised occupational disease, a suspected occupational 
disease, or some injuries that are reimbursed as occupational accidents. TLV and the 
Finnish Farmers' Social Insurance Institution Mela provide information related to 
recognised or suspected cases of occupational disease to FIOH. Information provided 
to the occupational health authorities by physicians are used to complete this 
information, especially with regard to respiratory allergies and skin diseases. FROD 
combines and corrects information that it has received from TLV and MELA about 
recognised and suspected occupational diseases to conform to the register’s 
statistical basis. In certain instances, this processing leads to a situation in which 
several individual cases in the TLV material are summarised to one statistical case in 
the FIOH material. Because the information is managed by FIOH, its cases are not 
comparable to the TLV cases. 
In addition to the total number of cases of recognised and suspected occupational 
diseases, FROD also publishes a separate list of cases recognised as an occupational 
disease by the insurance institutions. A recognised case of occupational disease is 
one for which the insurance institution has received sufficient evidence and has 
decided to consider the processed case to be an occupational disease. The number of 
cases recognised as an occupational disease represents the data that have been 
notified to FIOH. The number increases later as some of the cases of suspected 
occupational disease are confirmed as the investigation progresses. Therefore, in 
future publications, the number of recognised cases of occupational disease for 
previous years is always somewhat higher (see Occupational Diseases in Finland, an 
annual publication of FIOH). 
In 2010, a total of 149 cases of cancer suspected to have been caused 
by asbestos was reported (in 2009, 152 and in 2008, 158). The 
number of notified cases of respiratory cancer and mesothelioma was 
 Memorandum from the Occupational Cancer Working Group 
 
? 29 
93 and 55, respectively. There was 1 other cancer case suspected to 
have been caused by asbestos. The number of reported cases of 
mesothelioma in 2007–2010 was higher than earlier. In 2005 and 
2006, the average number of cases was 39 per year, whereas, in 
2007–2010, it was 60 cases per year. The number of reported cases of 
respiratory cancer, on the other hand, has remained the same (for 
2005–2006 an average of 88 cases and for 2007–2010 an average of 
87 cases). According to the Finnish Cancer Registry, the 
manifestations of mesothelioma, which have also been considered to 
be indicators of exposure to asbestos on the population level, have 
been as follows (5-year periods): 69 cases (1994–1998), 76 cases 
(1999–2003), and 92 cases (2004–2008). In 2010, 91 new cases of 
mesothelioma were reported to the Cancer Registry. There were also 9 
cases of cancer caused by something other than asbestos reported. 
These cancers included 1 lung cancer, 3 urinary tract cancers, 2 nasal 
cavity cancers, 2 cases of leukaemia, and 1 lymphoma. Of these 
cancers, 1 nasal cavity cancer caused by exposure to hardwood dust 
was recognised as an occupational cancer. Of all the diseases related 
to asbestos, insurance institutions recognised 65% as occupational 
diseases. However, the proportion of recognised mesotheliomas was 
85%. The percentage being higher than the average proves that both 
the diagnostics and the assessment of exposure were clear. Since 
there are good practices for diagnosing cases of asbestos-related 
occupational disease, changes in legislation have less influence on 
them than on many other types of occupational disease (Oksa et al., 
2012). 
Full coverage in the registering of occupational diseases has not yet been achieved. 
Some physicians neglect their responsibility to report occupational diseases. 
Furthermore, not all physicians and patients associate the disease to the work 
environment, probably because a long delay of possibly decades and missing work 
environment information. In general, especially for cancers receiving compensation 
as occupational diseases, there is underreporting. Underreporting is caused, for 
example, by the difficulty of physicians to identify the relation between work and an 
individual case of cancer, as well as by the extended latency periods typical of 
cancers, both of which make it difficult to identify risk factors and occupational 
exposure. An example of severe suspected underreporting is the situation in 
Portugal, where, in a population of 10.5 million, cancers have been reimbursed as 
occupational diseases in only 21 cases during the last 10 years. In Finland, most of 
the cancers that have been identified as occupational in origin are caused by 
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exposure to asbestos, whereas all other causes easily remain unrecognised. This 
situation suggests underreporting caused by underdiagnosis. 
2.4 Problems with compensation 
Compensation for cancer as an occupational disease is based on the same accident 
insurance legislation as the compensation for other occupational diseases. The 
precondition for receiving compensation is that the primary cause of cancer has 
probably been work-related exposure. The clinical description and microscopic 
structure of occupational cancers are, in most cases, no different from cancers not 
related to work. Since purely medical evidence cannot solve the occupational nature 
of cancers, compensation decisions are made according to a diagnosis based 
primarily on exposure information. Because of the long latency period, it is generally 
difficult to gather data on exposure. On the basis of current legislation, the critical 
question is whether individual cases of cancer are due to exposure at work or not. As 
cancer cases are processed according to the same legislation as other occupational 
diseases, the same principles must be followed as with occupational diseases in 
general when causation is assessed. 
When occupational diseases are considered for compensation, the decisions are 
based on the assumption that the disease in question has been identified as being 
caused by exposure at work for the person in question. For a known occupational 
disease, this causation has usually been proven in the scientific literature beyond 
dispute. 
The problem with occupational diseases is that the diseases themselves must be 
diagnosed in the first place. In the question of cancer, the problem differs in the 
sense that the actual cancer diagnosis can usually be made with reasonable 
certainty. For example, regarding lung cancer, the disease is often determined by its 
microscopic classification. An accurate diagnosis does not, however, offer any 
information about the cause of the cancer. 
The commonest cause of lung cancer is still smoking. Many work-related exposures, 
however, individually increase the risk of lung cancer. Therefore, cancer incidents 
have been considered to be cases of occupational disease when a significantly 
elevated risk of lung cancer is known to be associated with the exposure in question. 
Because the proportional effect of possible simultaneous smoking in the origin of 
cancer cannot be reliably evaluated, it has become common practice to compensate 
the incident as an occupational disease regardless of the patient’s smoking 
background. Thus far, in current compensation practices, cases have been decided 
primarily according to the following three criteria: 
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1. Factors proven to cause cancer among humans 
2. Factors with a strong enough effect on cancer causation 
among humans 
3. The employee has been significantly exposed to a cancer-
causing agent at work. 
On the other hand, cases in which there is epidemiological evidence that exposure to 
a substance would increase the risk of cancer also among humans but that this 
increase is relatively small have not been considered for compensation. Examples of 
such cases are the lung cancers of foundry workers, which have not received 
compensation as an occupational disease because of the only slightly increased risk 
ratio. 
Despite the aforementioned criteria, establishing an accurate cancer diagnosis and its 
effect on compensation is sometimes problematic when it comes to mesothelioma. 
Diagnostics in general may be very difficult, and diagnosing mesothelioma is 
especially challenging with regard to histology and requires special expertise. In 
ambiguous cases, it is common practice to ask for a statement from the 
Pneumoconiosis Specialist Group or the Mesothelioma Panel of FIOH if the opinion of 
FIOH experts has not already been noted. 
Sometimes there are also problems with the compensation for widely spread cancer 
cases, in which thorough diagnostic investigations may have to be abandoned on the 
basis of the poor general condition of the patient or a hopeless prognosis. In such 
cases, for example, mesothelioma may remain undetected or be detected only after 
the patient has died. Some cases of lung cancer may also lead to similar situations. 
Occupational diseases cannot, however, be confirmed on the basis of suspicion, and 
therefore, in these cases, an occupational disease cannot be diagnosed or the 
diagnosis can be made reliably only after the death of the patient. 
When cancer cases are assessed for possible compensation, most of the problems 
are caused by the evaluation of exposure. Exposure data are gathered both during 
occupational disease investigations in the hospital and in occupational health clinics. 
Insurance institutions, for their part, gather information using questionnaires directed 
towards the patient and his or her previous employers. The quality of the information 
deteriorates as more time has passed since the exposure ended. Often the patients 
themselves do not know exactly where and when exposure has occurred, and the 
employers are no longer available for questioning. Therefore, information about 
exposure varies, data collection takes a long time, and insurance decisions, as well 
as compensations, are thus delayed. 
 Memorandum from the Occupational Cancer Working Group 
 
? 32 
3 SITUATION IN SOME EUROPEAN COUNTRIES 
In 1990, the European Commission (EC) published its recommendation for 
occupational diseases (90/326/EEC), and the member states were encouraged to 
index their occupational diseases according to the pertinent appendix to the 
recommendation. In 1998, the statistical department of the EC (Eurostat) gathered 
sample statistics on incidents occurring in 1995. The analysis of this sample of 
statistics revealed significant problems in coverage, compensation practices, and 
compensation criteria, all of which made comparisons difficult. In 2003, the EC 
finished work on revising the recommendation and its appendices (2003/670/EC, 
notified in document C(2003)3297). The European list of occupational diseases in 
this recommendation contains items classified according to both pathogen and 
diagnosis. 
Data on recognised occupational diseases with diagnostic definitions are provided to 
the EC (Eurostat) annually. The list contains 68 primarily reported and 41 voluntarily 
reported diagnoses. Only the occupational disease items that occur in the 
occupational disease lists of all, or at least most, of the member states are included 
in this EODS information. Of the recognised occupational diseases in 2010, 2246 
(96%) could be classified according to the appendix. As the information from 
different countries is still inconsistent, Eurostat has not yet begun publishing its 
gathered data. 
The Occupational Cancer Working Group has primarily investigated cancers that have 
been recognised as occupational diseases from an international point of view using a 
questionnaire sent to insurance institutions dealing with occupational diseases in 14 
European countries. This questionnaire was primarily intended to determine the 
criteria used for the compensation of cancers as occupational diseases in these 
countries, as well as to collect data on the numbers of cancer cases considered to be 
occupational diseases. Replies were received from the following six countries: Spain, 
Portugal, Sweden, Germany, Switzerland, and Denmark. The Working Group also 
focused on studies made by the French research institute Eurogip concerning the 
compensation of occupational cancers and asbestos-related diseases in Europe. 
These studies can be obtained in electronic format from the Eurogip home page 
www.eurogip.fr.  
The occupational nature of cancers, as well as other diseases, can be verified from 
national occupational disease insurance institutions that reimburse them as 
occupational diseases. However, national social security systems, which also include 
accident and occupational disease insurance, have not been standardised at the EU 
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level, which basically means that the preconditions for the compensation of 
occupational diseases in each member state are still based on the national norms of 
each individual country. If these national preconditions are met and an occupational 
cancer is accepted for compensation as an occupational disease, the insured person 
receives compensation according to the national occupational disease insurance 
system, which in turn is dependent on the national norm. 
The social security regulations of the EU (especially regulations 
883/2004 and 987/2009 ratified on 1 May 2010) only govern which 
country’s social security legislation applies to a person travelling in the 
EU; in other words, their purpose is to aid the coordination of the 
national social security systems. The preconditions of receiving social 
security can still be defined on a national level as long as the general 
principles of the regulations concerning, for example, the demand for 
equal treatment are not infringed upon. Furthermore, employees must 
not lose their right to social security when they move from country to 
country. 
The social security regulations of the EU (883/2004 and 987/2009) 
contain rules on occupational diseases, and they are related to 
situations in which a person has been exposed to the same risk in 
several EU countries or the occupational disease grows worse in the 
EU. The aforementioned regulations amended the previous social 
security regulations (1408/71 and 574/72), but the basic principles 
concerning occupational diseases remained unchanged. 
When a person has developed an occupational disease and has been 
exposed to the same risk that causes an occupational disease in several 
member states, the compensation is paid according to the legislation of the 
last of these countries. The institution granting the benefits is the 
competent institution of that country (883/2004, art. 38 and 1408/71, art. 
57). 
If a person who develops an occupational disease becomes employed 
in another member state and has not been exposed to the pathogen in 
question in that state, the decision-making institution that originally 
furnished compensation for the occupational disease is also 
responsible for the aggravation of the disease. This institution must 
bear the cost of the benefits under the provisions of the legislation to 
which it applies and take into account the aggravation. If, on the other 
hand, a person has been employed in another member state and is 
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still exposed to the pathogen in that state, the responsibility for the 
aggravation of the disease is transferred to this state (883/2004 art. 
39, 1408/71 art. 60). 
More-detailed instructions about the application of EU regulations to 
occupational disease issues have been given in Employment Accident 
Compensation Board circulars 2/2010 and 2/2011, which are 
specifically related to social security regulations. 
In almost all of the European countries included in the Working Group’s investigation, 
the fundamental basis of the compensation regulations for occupational diseases was 
a nationally confirmed list of occupational diseases. Depending on the system, these 
lists create more or less strong suppositions that a disease included in the lists is to 
be recognised as an occupational disease (the list system). The level of detail in 
these national occupational disease lists varies significantly. For example, the French 
list of occupational diseases is very detailed and contains an exact table of possible 
diseases, exposures, and approval criteria, whereas, in Switzerland, the occupational 
disease regulation contains a relatively generic list of different exposures and 
possibly related diseases. 
The more or less varying occupational disease lists are complemented in most 
European countries by the off-list or complementary system of recognition, according 
to which a disease not mentioned in the occupational disease list can also be 
recognised as an occupational disease provided that, in individual cases, sufficient 
probability of cause and effect can be identified between the suspected occupational 
disease and exposure in a particular occupation. An example of such a 
complementary system of recognition is the Danish one, in which a disease not 
mentioned in the occupational disease list can be recognised as an occupational 
disease if the national body processing occupational diseases (Occupational Diseases 
Committee) considers the individual disease to be very probably (beyond reasonable 
doubt) caused by special occupational factors. 
The most important exceptions to the European combinations of occupational disease 
lists and recognition procedures are the Swedish and Spanish systems. In Sweden, 
the recognition of occupational diseases is based on a proof system, based on the 
premise that all diseases can be recognised as occupational diseases provided that 
an individually diagnosed occupational disease can be proven to have been caused 
by occupational exposure. In Spain, the premise of the occupational disease system 
is that a disease can be recognised as an occupational disease only if it has been 
mentioned in the national list of occupational diseases, and no diseases outside the 
list can be recognised as an occupational disease. 
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The German system can also be considered as one kind of an exception to 
combinations of occupational disease lists and recognition procedures. In its system, 
the preconditions for the compensation of occupational diseases have been defined in 
reasonable detail in the list of occupational diseases. Its list is, however, open by 
nature and can be expanded thanks to the supplement clause of the Decree on 
Occupational Diseases. According to the supplement clause, new diseases can be 
added to the occupational disease list, which currently contains 73 items, provided 
that 
? There is medical evidence that certain exposure causes certain a disease 
(general causation) 
? A certain group of people is more exposed than the rest of the population 
(group-specific characteristics). 
On an individual level, the recognition of a disease as an occupational disease 
requires, also in Germany, that the disease has been included in the list of 
occupational diseases and that there is causation between the disease and the 
patient’s occupation.  
In Finland, more-detailed criteria supplementing the general regulations of the 
Occupational Disease Act and its amendment, according to which a case of cancer 
can be recognised as an occupational disease, are primarily based on the report of 
the Occupational Cancer Working Group of 1988. Similar supplementing instructions 
or recommendations have been issued also in some other European countries. For 
example, the Swiss National Accident Insurance Fund SUVA, which manages accident and 
occupational disease insurance in Switzerland, has issued instructions on how several 
diseases can be recognised as occupational diseases. 
For example, SUVA has issued such complimentary instructions for the compensation of 
asbestos-related malignant tumours. In some European countries, exact compensation 
criteria for cancers, as well as other diseases, have already been defined in legislation, 
and no supplementary instructions or recommendations have been issued. An 
example of such a country is Spain, whose list of occupational diseases is included in 
national legislation and contains very specific criteria for the preconditions of a 
disease that is to be recognised as an occupational disease.  
Because of the aforementioned significant differences in the methods used for 
defining the compensation practices of occupational diseases in different countries, it 
is extremely difficult to create an all-inclusive list of cancers or exposures that could 
possibly be recognised in European countries. The occupational disease lists of the 
investigated countries are very heterogeneous with respect to the listed types of 
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cancer, as well as exposures. In most countries the occupational disease lists are also 
open by nature in the sense that, in addition to the cancers and exposures 
specifically included in the lists, also other types of cancer or cancers caused by other 
types of exposure can be recognised as occupational diseases in individual cases 
through different national recognition practices. 
The World Health Organization (WHO) and its subordinate IARC have often declared 
that the reliable assessment of the numbers of occupational cancers is extremely 
difficult on a global scale. The same applies to the assessment of the numbers on the 
EU or individual member state level. Some conclusions can naturally be drawn on the 
basis of the numbers of occupational cancers that receive compensation as 
occupational diseases. A general estimate is, however, that the numbers in 
occupational disease statistics do not begin to tell the whole truth about the extent of 
this phenomenon.  
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4 REVIEW BY EXPOSURE 
4.1 Asbestos and cancer 
 
 
IARC classifies asbestos as belonging to Group 1, carcinogenic in humans. The EU 
classification for asbestos is also 1 (CLP Group 1 A). 
In Finland, over 300 000 tons of asbestos have been used since the 1910’s, most 
abundantly in the 1960’s and 1970’s. Most of the asbestos was used in building 
materials. In addition, employees were exposed to asbestos in shipbuilding, the 
manufacturing of asbestos-containing products, and car and machinery maintenance. 
Asbestos materials were also used as protection against heat, as friction material in 
brakes and clutches, and in several other applications because of its technical 
properties. The use of chrocidolite asbestos was banned in 1976. The use of other 
types of asbestos was still allowed until 1994, when their use was completely 
banned. In practice, all buildings completed before the ban on asbestos may contain 
asbestos in one form or another. 
The Asbestos Committee estimated that, in 1989, as many as 200 000 people had 
been exposed to asbestos: 150 000 in the building industry, 20 000 in shipyards, 20 
000 in auto repair shops, and 10 000 in the manufacturing of asbestos products. In 
the 2010’s fewer than 50 000 of these people were estimated to be still alive. 
Although the use of new asbestos has been banned, exposure is still possible in 
asbestos demolition work. Each year, 500–1000 workers with asbestos exposure are 
notified to the ASA register. Although the use of asbestos is banned and even 
demolition work can only be done by professionals, many workers are still exposed 
to asbestos. Because of the long delay between new exposure cases and the 
In this report, asbestos refers to the following fibrous silicates:
a) Actinolite asbestos, CAS No 77536–66–4
b) Amosite asbestos, CAS No 12172–73–5
c) Anthophyllite asbestos, CAS No 77536–67–5
d) Chrysotile asbestos, CAS No 12001–29–5
e) Chrocidolite asbestos, CAS No 12001–28–4
f) Tremolite asbestos, CAS No 77536–68–6.
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manifestation of health problems, asbestos-related diseases will still occur for a long
time. When it comes to asbestos, it must also be noted that the regulations and rules
governing the use of asbestos and demolition work, or the failure to adhere to them,
do not directly affect the decisions made by the insurance court regarding the
compensation of occupational diseases caused by asbestos. According to the
Occupational Disease Act, an employee always receives compensation for an
occupational disease if exposure at work is probable and the disease can be caused
by that exposure.
4.1.1 Cancers caused by asbestos
A long incubation period is typical for asbestos-related diseases. The number of
cancers caused by asbestos is estimated to peak in 2010–2015. Because of the
extended latency period, new cancer cases caused by asbestos will, however, be
diagnosed until the 2020’s or even the 2030’s among those exposed before the ban
of asbestos. According to IARC (2012a), there is sufficient evidence showing a link
between exposure to asbestos and an elevated risk of lung cancer, mesothelioma,
laryngeal cancer, and ovarian cancer. Limited evidence has been found for a
relationship between asbestos exposure and cancer of the colon, stomach, and
pharynx. The disease mechanism is considered to be the activation of macrophage
cells caused by asbestos fibres, an inflammatory reaction, the formation of reactive
oxygen and nitrogen compounds, tissue damage, genotoxicity, aneuploidy and
polyploidy, epigenetic changes, the activation of signalling pathways, and apoptosis
resistance.
4.1.1.1 Lung cancer
Asbestos fibres have been proven to increase the risk of all traditional types of lung
cancer (adenocarcinoma, squamous carcinoma, large-cell carcinoma, and small-cell
carcinoma). The current classification of lung cancers includes two other types that can be
considered to belong to the same group (adenosquamous carcinoma, with characteristics
of glandular and squamous carcinoma, and sarcomatoid carcinoma). There is no proven
association between the salivary gland-like carcinomas of the lung and exposure to
asbestos. Blue asbestos, (i.e., chrocidolite) is considered to be the most dangerous type of
asbestos, while the effect of chrysotile on the risk of cancer is considered to be weaker
than that of other asbestos fibres. In practice, the different types of asbestos are not
separated; instead all exposure to asbestos is combined. The risk ratio is linear. In an
international recommendation, an exposure level of 25 fibre-years doubles the risk of
cancer (see page 44 for the definition of fibre-year) (Asbestos, Asbestosis and Can-
cer, Scandinavian Journal of Work, Environment & Health, 1997).
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The level of exposure is also indicated by the number of asbestos bodies (AB) in
bronchoalveolar lavage fluid or lung tissue (optical microscope analysis), and the
number of asbestos fibres in lung tissue (electron microscope analysis, see page 44).
The latency period for lung cancer from the beginning of exposure to the diagnosis of
cancer is usually over 20 years (Nordman and Keskinen, 2005). Smoking and
asbestos increase each other’s effect on lung cancer. The development of asbestos-
related lung cancer does not require asbestosis.
Smoking does not affect the occupational cancer decision. Smokers are compared in
the same way as non-smokers are. Therefore, the magnitude of the risk caused by
asbestos is independent of smoking. The latency period is at least 10 years. The
methods recommended for determining the exposure level are screening
questionnaires or structured interviews in hospitals and other places of treatment,
and, if necessary, use of the centralised national (telephone) interview service of the
Finnish Institute of Occupational Health (FIOH), as well as consultation with
occupational medicine clinics and pneumoconiosis specialist groups. The
questionnaire should be the same for all users.
4.1.1.2 Malignant mesothelioma
Asbestos and erionite, CAS No 12150–42–8, are the known pathogens for malignant
mesothelioma. The disease mechanisms are related to the size and shape of these
fibres, as well as to their biopersistence. Chrocidolite is the strongest pathogen,
whereas the risk caused by chrysotile is significantly lower. Mesothelioma usually oc-
curs in the pleura or peritoneum. All cases of malignant mesothelioma of the pleura
or peritoneum can be caused by asbestos.
The latency period for malignant mesothelioma is usually long, up to 50 years.
Exposure at work does not have to be severe or long-lasting. Exposure of even a
couple of weeks has been shown to cause the disease. Malignant mesothelioma has
also been found among the families of asbestos workers. Smoking has no effect on
morbidity.
4.1.1.3 Laryngeal cancer
IARC has added laryngeal cancer to the list of cancers caused by asbestos (Group 1)
(IARC, 2012a). The risk ratio is linear and follows the risk level of lung cancer.
In a meta-analysis of cohort studies, the relative risk was reported to be 1.4 [with a
95% confidence interval (CI) of 1.2–1.6] for all of the patients exposed to asbestos.
When the risk was compared between those with high exposure and those with no
exposure, the risk ratio was 2.0 (95% CI 1.6–2.5) (Institute of Medicine, 2006).
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The relation between the risk of lung cancer and laryngeal cancer has been studied in 
the following recent publications: Musk et al., 2008; Pira, 2005; Finkelstein and 
Verma, 2004; Karjalainen et al., 1999. According to these publications the risk 
relations are similar. The same compensation practices apply to both laryngeal 
cancer and lung cancer. 
4.1.1.4 Ovarian cancer 
IARC has added ovarian cancer to the list of cancers caused by asbestos (IARC, 
2012a). The risk ratio is linear. In cohort studies, it has been discovered that, for 
women who have been highly exposed to asbestos at work, there is an elevated 
morbidity of ovarian cancer. This is the case, for example, among women who 
manufactured gas masks in a British factory during the Second World War (Acheson 
et al., 1982). According to another study, asbestos collects in the ovaries of exposed 
women (Heller et al., 1996).  
4.1.1.5 Other types of cancer 
A group of IARC specialists considered the evidence of a relationship between 
exposure to asbestos and colorectal cancer to be limited. The evidence of asbestos 
causing cancer of the pharynx and stomach was also considered limited (IARC, 
2012a). 
When it comes to colorectal cancer or cancer of the pharynx and stomach, the 
evidence concerning asbestos aetiology is limited. According to current knowledge, 
these types of cancer cannot be considered occupational. 
4.1.2 Procedures in suspected cases of occupational cancer 
When a case of cancer is suspected to be an occupational disease caused by 
asbestos, exposure data and a differential diagnosis of the disease are required 
before the issue is decided. The occupational health specialists and occupational 
medicine clinics are experts in evaluating the exposure. If necessary, consultation 
with the pneumoconiosis specialist groups of FIOH and university hospitals, as well 
as with experts with the Mesothelioma Panel, can also be carried out. The incident is 
also reported to the occupational safety authorities. 
4.1.2.1 Exposure 
The level of exposure is determined primarily by studying the employee’s work 
history. Information is gathered from the employee, employers, and the literature. 
The entire work history is taken into account in an interview. The employee can ask 
for his or her employment information from the Finnish Centre for Pensions. Different 
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periods of exposure are combined. The level of exposure should be estimated and 
calculated as fibre-years of exposure. 
  
Exposure level (fibres/cm3) x exposure period (years) = fibre-years 
 
A low level of exposure is considered to be fewer than 10 fibre-years. Moderate 
exposure is 10–24 fibre-years, and high exposure requires 25 fibre-years or more. 
The employers and tasks exposing the employee to asbestos are recorded, as are 
the first and last year of exposure and the name of the employer at the time. 
Occupational hygiene measurements may be available from the employers. 
Information about the materials containing asbestos, exposure levels at different 
times, and occupations can be found in the following books: Riitta Riala: Asbesti 
purkutöissä [Asbestos in Demolition Work] (FIOH, Helsinki 1989); Riitta Riala: 
Asbesti [Asbestos], No. 5 in the series Altisteet työssä [Exposure at Work] (FIOH, 
Helsinki 1992); and Kari Vikström: Asbestipitoiset tarvikkeet [Materials Containing 
Asbestos] (95033) (The Centre for Occupational Safety, Helsinki 1995).  
Table 4 presents the exposure levels found in different occupations. The table is 
based primarily on industrial hygiene measurements carried out in Finland during the 
1970’s and 1980’s, the literature, research, and empirical experiences of both 
industrial hygiene experts (Linnainmaa M, Tuomi T) and occupational medical 
experts (Oksa P, Uitti J). The table helps to determine the situations in which high 
exposure (= 25 fibre-years or more) has been possible. The information in the table 
represents the “average truth” of an industry, occupation, or task and is therefore 
useful if there is no exact data available on the employment of the patient. On an 
individual level, however, the “average truth” may lead to exaggerations or 
understatements. Therefore, an attempt should be made, if possible, to hold 
interviews or otherwise gather more-detailed information about the work tasks and 
exposures during the patient’s entire career. When an understanding about all of his 
or her occupations, including exposure and its duration, is reached through 
interviews, the patient’s asbestos exposure in fibre-years can be calculated more 
accurately. 
Exposure has been possible even after 1994. According to the experience of FIOH 
experts, measurements taken from the inside of asbestos demolition workers’ 
respirators have usually been 0 fibres/cm3. In other words, any exposure has 
probably been “accidental” (i.e., materials have been demolished without them being 
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known to contain asbestos) or the exposure has been related to work methods or 
lack of protection. Asbestos diseases have also been reported among persons who 
have been working in demolition only after 1994 (Ylioinas et al., 2012). 
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Table 4. Normative exposure levels for different occupations (Linnainmaa, Oksa, Tuomi, 
Uitti).  
Exposure level/year, 
fibres/cm3 
Construction–1980   0.5  
Asbestos spraying <1977  100 
Pipe insulation   25 
Machining of asbestos concrete plates <1986 20 
Construction 1981–1994   0.3 
Renovation 1950–1994   1 
Demolition of asbestos insulation <1987 25 
Water and sewage pipework (municipal engineering) 0.3 
Shipbuilding <1977   5 
Asbestos spraying <1977  100 
Shipbuilding 1978–1988   3 
Vehicle brake and clutch repair work <1988   0.2 
Maintenance and installation work   0.3 
(Handling of gaskets, filters, 
insulating paste, etc. Containing asbestos)  
Asbestos product manufacturing <1989  
Asbestos concrete manufacturing <1970 33 
Asbestos concrete manufacturing 1971– 2 
Asbestos concrete product manufacturing 1 
PVC tile manufacturing <1980  4 
PVC tile manufacturing 1981–  1 
Asbestos cardboard manufacturing 10 
Textile manufacturing  5 
Bitumen product and paint manufacturing 1 
Mining industry and rock handling, 
with knowledge of asbestos   0.2 
Asbestos mines <1976   10 
Drilling and hauling  55 
Enrichment <1969  200 
Enrichment 1970–  10 
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Rows in italics in Table 4 are estimates of the generic exposure level of an industry. These estimates
include exposure to dust caused by others, as well as sporadic exposure in one’s own work. A detailed
work history may therefore change the exposure level.
Exposure is also indicated by asbestos bodies (AB) in the bronchoalveolar lavage
fluid. These bodies are formed when a person’s body covers asbestos fibres with
protein in order to eliminate their harmful effects. Determination is made from the
bronchoalveolar lavage fluid collected from the (centre section) of the bronchial
pathway during bronchial endoscopy using an optical microscope. The results are
measured in AB/ml. A result of over 1 AB/ml indicates occupational exposure to
asbestos (Asbestos, Asbestosis and Cancer: the Helsinki Criteria for Diagnosis and
Attribution: Consensus Report. Scandinavian Journal of Work, Environment & Health
1997; 23: 311–316).
Asbestos bodies can also be assessed from histological tissue samples. The limit used
in an international recommendation (Helsinki Criteria) is 2 or more asbestos bodies
per square centimetre. Finland is practically the only country in which anthophyllite,
which has a strong tendency to form asbestos bodies, has been primarily used.
Therefore, in Finland, the appearance of asbestos bodies is common. The formation
of asbestos bodies not only depends on the type of asbestos, but also on the
person’s tendency to form asbestos bodies and possibly also, for example, on the
iron content of the air breathed. Therefore, the percentage of coated asbestos fibres
from the total asbestos fibre content in the lung tissue varies, and a small number of
asbestos bodies does not rule out a high exposure level. For these reasons, it is
possible to overestimate or underestimate exposure that is based on asbestos
bodies, and the results must be compared with the work history and an asbestos
fibre analysis.
A transmission electron microscope (TEM) is used determine asbestos exposure from
a sample of cremated lung tissue. The sample should represent normal lung tissue
and not, for example, cancer tissue or fibrosis. According to the Helsinki Criteria
document, occupational exposure is indicated by one million fibres per gram of dry
lung tissue. A high level of exposure to asbestos is indicated by two million amphibole
fibres (>5 µm) or five million amphibole fibres (>1 µm) per gram of dry lung tissue. The
determination of chrysotile asbestos exposure according to fibre analysis is uncertain be-
cause chrysotile is removed from the body faster than other types of asbestos. The de-
termination limits vary between laboratories. According to the current practices of the Fin-
nish Institute of Occupational Health (FIOH), high exposure (sufficient to cause lung can-
cer or asbestosis) is considered to be a value in excess of 2–3 million (>1µm) fibres per
gram of dry lung tissue.
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It is not justifiable to take lung tissue samples only for determining exposure to 
asbestos. Lung tissue can, however, be used if histological samples have been 
extracted for other reasons (removal of the lung or a part of it, diagnostic biopsies for 
determining the cause of lung fibrosis, etc.). In autopsies, the main indication may 
be a suspicion of occupational disease, and, in such cases, samples should be taken 
for fibre analysis.  
Coroners have set up guidelines to help them determine occupational diseases 
related to asbestos (handout 23 February 2011, Occupational Diseases in Establishing 
Cause of Death in Forensic Medicine and Compensation Practices for Occupational 
Disease, Final Report, 20 March 2012). In addition, the occupational health 
committee of the Finnish Ministry of Social Affairs and Health has decided that there 
is no need to perform a forensic autopsy if the patient’s death is caused by lung 
carcinoma or mesothelioma that has been accepted as an occupational disease. In 
such cases, it is enough that the cause of death is established by the police on the 
basis of documents and the medical certificate. Regulatory guidance is being 
prepared by the Finnish Ministry of Social Affairs and Health. 
4.1.2.2 Lung cancer among asbestosis patients 
Exposure to asbestos can cause lung cancer without asbestosis. The emergence of 
asbestosis requires moderate or high exposure and sufficient latency. According to 
some studies, the risk of lung cancer among asbestosis patients is 2–5 (IARC, 1987). 
For Finnish asbestosis patients, the risk has been determined to be 8 (SMR) and 10 
(SIR) (Oksa et al., 1997).  
If a lung cancer patient has asbestosis visible in an imaging analysis or it can be 
microscopically verified (pathological-anatomical diagnosis), the cancer patient can 
receive compensation as an occupational disease. 
4.1.2.3 Diagnostics and tracking of asbestos exposure, lung cancer screening 
There is a legal obligation to keep track of workers who have been exposed to 
asbestos even after their exposure and work careers have ended. The used 
follow-up methods have been described in the guidebooks Terveystarkastukset 
työterveyshuollossa [Medical Checks-ups in Occupational Healthcare] 
(Työterveyslaitos, 2006) and Asbestisairauksien diagnostiikka ja seuranta 
[Diagnostics and Follow-up of Asbestos-related Diseases] (Nordman et al, 
2006). Practical instructions can also be obtained from the website of the 
Finnish Respiratory Association [Hengitysliitto] www.heli.fi, for example, the 
guides Vaarallinen asbesti [Dangerous Asbestos] and Asbestialtistuneen 
muistilista [Checklist for People Exposed to Asbestos]. 
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Lung cancer screening may decrease mortality. The National Lung Screening Trial 
(NLST, 2011) compared low-dose computed tomography (CT) scans to chest 
radiographs when screening people with a high risk of lung cancer. This study 
covered 33 research locations in the United States, and it screened 53 000 current or 
ex-smokers who were symptomless. The participants were randomly selected three 
times for yearly CT scans or chest radiographs. The follow-up lasted for about 6.5 
years. In October of 2010, the independent Data and Safety Monitoring Board 
interrupted the study. There had been 354 deaths caused by lung cancer among the 
people followed by CT screening (of about 26 500 people) and 442 among the 
control group. Lung cancer mortality decreased a statistically significant 20%. In 
other words, deaths caused by lung cancer decreased by 88 cases per 26 500 
persons screened – 1 for every 300 people. In addition, the total mortality of the 
screening group decreased. According to a review published in June 2012, lung 
cancer screening using low-dose CT may be beneficial for certain exposed groups, 
but the possible harmful effects of the screening, as well as how the results can be 
applied to other exposed groups, was still unclear (Bach et al., 2012). 
4.1.2.4 Forensic pathology 
It would be desirable for occupational disease issues to be clarified while the patient 
is alive. This problem was addressed in an earlier report by a committee of the 
Finnish Ministry of Social Affairs and Health (Ammattitaudit oikeuslääketieteellisessä 
kuolemansyynselvityksessä ja ammattitautikovausjärjestelmän käytännöt, 
Loppuraportti 20.3.2012 [Occupational Diseases in Forensic Pathology and the 
Compensation Practices for Occupational Diseases, Final Report 20 March 2012]). 
Statutory forensic pathology is, however, very important in the diagnosis of 
occupational diseases, especially if the investigation process is not finished or has not 
been started. When it comes to a police investigation and a possible forensic 
autopsy, it is extremely important that as detailed an occupational history as possible 
is available for the patient, as well as information about possible ongoing processes 
in the insurance system. The aforementioned committee of the Finnish Ministry of 
Social Affairs and Health has decided that there is no need to perform a forensic 
autopsy on a patient who has died from lung carcinoma or mesothelioma if the case 
has been accepted as an occupational disease. In such cases, it is enough that the 
cause of death is established by the police on the basis of documents and the 
medical certificate. 
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4.2 Quartz 
 
An international cancer research institute (IARC/WHO) has determined that quartz 
and cristobalite are carcinogenic in humans (Group 1, IARC 1997). This assessment 
was updated in 2009 (Group 1, IARC 2012a). In a meta-analysis concerning all 
patients with silicosis, an elevated risk of lung cancer was detected for patients with 
silicosis [risk ratio (RR) 1.7–2.8)] (IARC 2012a, Table 2.3). In a meta-analysis in 
which silicosis patients were not separated from those without silicosis, the relative 
risk point estimates for lung cancer were 1.3–1.4 (IARC 2012a, Table 2.3). 
The most recent meta-analysis was carried out by Erren et al. (2009) (38 studies 
until January 2007). According to this analysis, the relative risk of lung cancer for 
patients with silicosis was 2.1 (95% CI 2.0–2.3). There was no risk of lung cancer for 
those without silicosis, the risk ratio being 1.0 (95% CI 0.8–1.3). The analysis was 
based on three studies in which the proportion of smokers was notable. For eight 
studies in which smoking was not controlled, the risk of lung cancer for those without 
silicosis was about 1.2 (95% CI 1.1–1.4). 
In addition to the analysis by Erren et al. (2009), IARC has published tables on two 
other meta-analyses in which the risk of lung cancer was assessed in a group of 
people exposed to quartz, but without silicosis (IARC 2012, Table 2.3). When the 
cohort and case-control studies of Kurihara and Wada (2004) were combined, the 
risk ratio was 1.0 (95 % CI 0.8–1.2). In the cohort study of Pelucchi et al. (2006), it 
was 1.2 (95% CI 0.9–1.6), and in their case-control study it was 1.0 (95% CI 0.7–
1.4). 
The assessment of the association between cumulative exposure to quartz and lung 
cancer morbidity has yielded mixed results. In the meta-analysis (10 studies) by 
Lacasse et al (2009), the cumulative exposure to quartz was found to be related to 
an increased risk of lung cancer. The results were nevertheless heterogeneous. The 
interpretation of the results is made difficult by the fact that the material contained 
people with and without silicosis, and these groups could not be analysed separately. 
Therefore, Lacasse et al. did not answer the question of whether the risk of lung 
cancer is elevated among people exposed to quartz but do not have silicosis. 
The exposure to quartz and the mortality of granite workers in Vermont has been 
monitored for 100 years in studies that have been significant in developing the 
standards for quartz in the United States. The latest analysis concerning the 
mortality of 7052 employees was published in 2011 (Vacek et al., 2011). The lung 
cancer mortality of the employees was higher than expected (SMR 1.4, 96% CI 1.2–
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1.5), but no association was found between the cumulative exposure to quartz and 
lung cancer morbidity (OR 1.0, 95% CI 0.9–1.0). The slight increase in lung cancer 
mortality was attributed to smoking or other types of exposure.  
A large cohort study in the German porcelain industry has analysed silicosis 
morbidity and lung cancer mortality in relation to work history and the results of 
8000 industrial hygiene measurements. The cumulative exposure to quartz was 
found to be strongly associated with silicosis morbidity, but not with lung cancer 
mortality (Mundt et al., 2011). 
There is uncertainty in the interpretation of the results of epidemiological cancer 
studies because quartz is a weak carcinogen. The meta risk ratio for lung cancer 
among silicosis patients is about 2, and the risk estimate is significantly lower when 
people without silicosis are also included in the same analysis (meta RR 1.3–1.4). 
Epidemiological studies on the carcinogenicity of quartz can be distorted by the 
following factors:  
? structure of the material and quality of the follow-up; 
? separate analysis of people with silicosis and those without it; 
? confounding effect of other types exposure; 
? effect of smoking; 
? differences between socioeconomic groups; 
? comparability of control material; 
? selective bias in association with occupational disease registers; 
? quality of data on cumulative exposure; 
? difficulties in defining dose–response; 
? selections and methods of a meta-analysis (problems with heterogeneity, 
sensitivity analysis); 
? problems and interpretations of statistical modelling, testing, and evaluation. 
In Finland, about 70 000 employees are exposed to quartz, especially in mining, 
quarrying and construction, foundry work, sand blasting using materials containing 
quartz, and in the manufacturing of glass, porcelain, cement, mortar, brick, concrete 
and other clay or stone products (Vainio et al., 2005). In the industrial hygiene 
measurements carried out in 2004–2007 by the Finnish Institute of Occupational 
Health (FIOH), a high quartz content [i.e., an occupational exposure limit (OEL) of 
over 0.05 mg/m3] was detected in mines, quarries, foundries, and a glass factory, as 
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well as in the manufacturing of roofing felt and concrete products (Saalo et al., 
2010). 
In conclusion, it can be noted that 
? IARC has classified quartz and cristobalite as being carcinogenic in humans 
? Patients with silicosis have a double risk of lung cancer  
? Not enough evidence exists about increases in risk among patients with lung 
cancer without silicosis. 
 
4.3 Other chemical factors 
 
This section primarily contains information about chemical substances whose 
carcinogenicity has been clearly proven. According to their carcinogenicity, these 
agents have, in most cases, been classified into Group 1 by IARC or into Category 1A 
by the EU. There are also some substances belonging to IARC Group 2A or EU Group 
1B, as well as, for example, nanoparticles, whose carcinogenic properties are not yet 
well known. These agents have been included in this report either because they are 
significant sources of exposure in Finnish worklife or because their possible 
carcinogenicity has lately caused concern. They include, for example, carbon 
nanotubes. 
4.3.1 Polycyclic aromatic hydrocarbons  
IARC has evaluated and classified several compounds and mixtures comprised of 
individual polycyclic aromatic hydrocarbons (PAH) according to their carcinogenicity. 
Of the individual PAH compounds, only benzo(a)pyrene has been classified into 
Group 1, whereas cyclopenta[c,d]pyrene, dibenzo[a,h]anthracene, and 
dibenzo[a,l]pyrene belong to Group 2A. A group of other, less studied individual PAH 
compounds have been classified into groups 2B and 3. Of the common PAH 
mixtures, IARC has classified coal tar, soot, coal tar pitch, and diesel exhaust into 
Group 1  and creosote and bitumen into Group 2B. IARC has also classified 
occupations that expose employees to PAH compounds as follows: occupational 
exposures during coal gasification, coal tar distillation, coke production, aluminium 
production, paving and roofing with coal tar pitch, and chimney sweeping are 
carcinogenic in humans (Group 1). Occupational exposures during carbon electrode 
manufacture are classified as probably carcinogenic in humans (Group 2A). 
Employees in foundries are also exposed to PAH compounds in addition to other 
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exposure (quartz and metal fumes). IARC has classified iron and steel founding into 
Group 1 (see Section 5.6). Certain fuel oils, such as kerosene and diesel fuel, may 
also contain over 5% PAH compounds. Heavy fuel oils and maritime diesel fuel have 
been classified into Group 2B by IARC, whereas light fuel oils and light diesel fuels 
have not yet been classified. 
The capacity of PAH compounds to cause cancer was first demonstrated already in 
1775 among chimney sweeps, who were diagnosed with testicular cancers caused by 
exposure to soot. In the 1900’s the capacity of PAH compounds to cause skin cancer 
was detected in animal test models when PAH compounds or mixtures were applied 
to the skin of animals. The association between PAH exposure and the risk of cancer 
has been researched in several epidemiological studies in different industries in the 
20th and 21st centuries. The strongest evidence for a relationship between 
occupational PAH exposure in relation to lung cancer has been found in coal 
gasification, coke production, and aluminium production. 
A comprehensive study concentrating on lung cancer mortality among 5321 coke 
oven workers in the United States and Canada in 1952–1982 showed that there was 
an increased risk of lung cancer among coke oven workers (Costantino et al., 1995). 
The risk was greatest among employees who had been exposed for 15–19 years and 
over 20 years (SMR 2.91 and 2.71, respectively) (Costantino et al., 1995). A meta-
analysis of 10 cohort studies carried out by Bosetti et al. (2007) showed, on the 
other hand, an increased risk of lung cancer (RR 1.58, 95% CI 1.47–1.69) among 
coke oven workers.  
Similar risk ratios for lung cancer have been detected in aluminium and gas 
production and also in coke oven work. The risk ratios in individual studies have 
mainly varied between a little over 1 and a little over 2 (IARC 2010a).  
In studies concentrating on employees exposed to creosote, elevated risks of skin 
cancer have been detected. In a Swedish cohort study among wood impregnators, 
an elevated risk of skin cancer (not melanoma) and lip cancer was detected (SIRs of 
237 and 250, respectively) (Karlehagen et al., 1992). Exposure to ultraviolet 
radiation may also have affected the risk. In a Finnish register-based study, an 
increased risk of lip cancer and skin cancer other than melanoma was detected for 
round timber workers who had (probably) been exposed to creosote (SIR 306 and 
464, respectively) (Pukkala et al., 1995). 
For roofing and paving work, there is primarily evidence of an elevated risk of lung 
cancer. In the United States, Hammond et al. (1976) noted a 2.47-fold risk of lung 
cancer for roofing employees who had been exposed for over 40 years. In their 
comprehensive American cohort study, Stern et al. (2000) found the relative risk of 
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lung cancer mortality among roofing employees to be 1.39. A wide European study 
(Boffeta et al., 2003a) did not indicate an elevated risk among paving employees. In 
a meta-analysis by Partanen and Boffetta (1994) on 20 studies, a risk ratio of 1.78 
was detected for roofing employees, whereas the risk ratio for paving employees was 
only 0.87 on the basis of three cohort studies. 
In a Swedish cohort study among 5313 chimney sweeps (Evanoff et al., 1993), it 
was noted that increased lung cancer morbidity correlated with career length. For the 
entire cohort, the risk of lung cancer was 2.09 (SIR), and, for those who had been 
exposed for 10–19 years, it was 2.19. For those who had been exposed for 20–29 
years, the risk was 2.68, and, for those exposed for over 30 years, it was 2.34. The 
risk of bladder cancer was also increased (SIR 2.53). The risk of cancer of the 
oesophagus was also elevated (SIR 3.87), but this value was based on significantly 
fewer incidents. Skin cancer risk was not elevated. In a register-based study carried 
out by Pukkala (1995), a lung cancer SIR of 1.35 was noted for chimney sweeps. 
WHO (2000) has estimated, based on epidemiological studies carried out among 
coke oven workers, that the individual risk of lung cancer caused by PAH compounds 
during lifelong exposure is 6.2 x 10-4 per 1 µg/m3 as a benzene-soluble fraction of 
total particulate matter.  
In Finland, employees have been exposed to PAHs especially in coke oven work, the 
creosote impregnation of wood, foundry work, work with coal tar, and coal tar and 
petroleum-based product manufacturing, as well as through exposure to exhaust 
fumes (Vainio et al., 2005). The exposure routes vary in different tasks; pulmonary 
exposure to PAHs is the most significant in coke oven work, whereas exposure in, for 
example, wood impregnation and the handling of impregnated wood occurs mainly 
through the skin. 
Summary: There is much evidence from different occupations on the association 
between PAH exposure and lung and skin cancer. The risk and type of cancer depend 
on the intensity and duration of exposure, as well as on its the primary route. The 
strongest evidence on the risk of cancer has been detected in coal gasification, coke 
production, and aluminium production. Exposure to creosote has been linked mainly 
to skin cancer. The dose–response ratios are unclear. 
4.3.2 Diesel exhaust 
In 2012, IARC classified the carcinogenicity of diesel exhaust as Group 1. 
The IRIS (Integrated Risk Information System) database lists over 30 
epidemiological studies about the carcinogenicity of diesel exhaust, ranging over 40 
years until the year 2003 (IRIS 2003). Most of these epidemiological studies have 
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concentrated on certain exposed groups of employees, such as railroad workers, 
truck drivers, machine operators, tractor drivers, and other operators of diesel 
engines. Some of the studies are reviews and meta-analyses of earlier research 
projects. 
An increased risk of lung cancer has been detected in 8 of 10 cohort studies. In 5 of 
these studies, the difference was statistically significant. An increased risk of lung 
cancer has also been detected in 10 of 12 case-control studies. In 8 of these, the 
difference was statistically significant. The average relative risk has varied between 
1.2 and 1.5. Independent meta-analyses have also detected statistically significant 
increases in risk (RR 1.33–1.47).  
In an ongoing, comprehensive case-control study (Olsson et al., 2009), the results of 
earlier studies from Germany, Italy, Sweden, France, and Canada have been 
combined. This study contains 13 412 cases and 16 320 controls. In this study, the 
OR of the group with the highest exposure was 1.36. A similar amount of increased 
risk (OR=1.2–1.6) was detected in a Canadian study (Parent et al., 2007), but it was 
not statistically significant.  
A doctoral dissertation published in Finland showed no clear increase in the relative 
risk of lung cancer caused by exposure to diesel exhaust (Guo, 2005). In a recently 
published case-control study among mining workers, which was based on 
comprehensive cohort material, the risk of lung cancer among the most-exposed 
group was about threefold (Silvermann et al., 2012). English scientists have 
estimated diesel exhaust to be among the most significant causes of occupational 
lung cancer (626 cases/year) (Rushton et al., 2008). In a similar study carried out in 
Finland, the current level of exposure to diesel exhaust has been estimated to be the 
cause of 9 new cases of lung cancer per year (Priha et al., 2010). 
There are no industrial hygiene limits set for diesel exhaust in Finland. According to 
industrial hygiene measurements, the exposure is highest when diesel vehicles are 
used in closed spaces such as tunnelling sites and mines. 
Summary: Although an association between exposure to diesel exhaust and lung 
cancer has been detected in epidemiological studies, the risk ratios have usually been 
relatively low, 1.2–1.5. 
4.3.3 Environmental tobacco smoke 
In 2002, IARC classified environmental tobacco smoke as carcinogenic in humans 
(Group 1). This assessment was based on a small, but consistent increase in the risk 
of lung cancer among the non-smoking spouses of smokers, which was detected in 
epidemiological studies, and also on the knowledge that environmental tobacco 
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smoke contains several of the known or suspected carcinogens found in smoke 
inhaled during active smoking (IARC, 2002).  
Among non-smoking people who have been exposed to environmental tobacco 
smoke in their homes, the risk of lung cancer has been estimated to be 1.2–1.3 
times the risk of people that have not been exposed in such a manner. In a meta-
analysis published in 2007, exposure to environmental tobacco smoke in the 
workplace results in a 24% additional risk of lung cancer (Stayner et al., 2007). The 
risk was affected by both the level and duration of exposure. Among the most 
exposed people, the risk was twofold. Some studies have also indicated a 
relationship between environmental tobacco smoke and cancer of the larynx or 
pharynx. The causality is, however, not as clear as it is with lung cancer (IARC, 
2002).  
Before legislation banning smoking in Finnish restaurants (effective since 1 June 
2007), over 40 000 restaurant employees were exposed to environmental tobacco 
smoke. Over 30 000 of them were exposed to tobacco smoke from customers or 
colleagues for over one-fourth of their annual worktime (Kauppinen & Virtanen, 
2002). The exposure levels in restaurants varied greatly; when measured as the 
nicotine content in air, the range was 1 µg/m3–100 µg/m3 (Kauppinen & Virtanen, 
2002). Exposure to environmental tobacco smoke also occurs, for example, in the 
metal industry, construction, penitentiaries, and many small workplaces. In these 
other workplaces, the exposure levels have been significantly lower. In addition to 
active smoking, also passive smoking at home is an important confounding factor 
when the effect of occupational exposure in the formation of lung cancer is being 
assessed. 
Summary: Although an association between exposure to environmental tobacco 
smoke and lung cancer has been detected in several epidemiological studies, the risk 
ratios have been relatively low (1.2–1.3). Therefore, proving that environmental 
tobacco smoke is a cause of individual lung cancer is difficult. 
4.3.4 Benzene 
Benzene is an IARC Group 1 carcinogen. In the EU, it has also been classified into the 
CLP Category 1A. The association between benzene and acute myeloid leukaemia is 
well known. Benzene has also been suspected to cause other types of haematological 
cancer, such as multiple myeloma and non-Hodgkin’s lymphoma. The evidence 
concerning these is, however, scarce.  
The latency period for leukaemia caused by benzene has usually been considered to 
be about 10 years or less. The information available about dose–response ratios 
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varies; according to some studies even exposure as low as 40 ppm-years (e.g., 40 
years to 1 ppm, parts per million) significantly increases the risk, whereas, in other 
studies, a significant increase was only detected at 40–200 ppm.  
In what is called the Plioform study, the risk of leukaemia (SMR) was 1.45 at the 
exposure level of 1–40 ppm-years, 3.21 at 40–200 ppm-years, 5.44 at 200–400 
ppm-years, and 23.96 at over 400 ppm-years (Rinsky et al., 2002). Based on these 
data, the relative risk caused by exposure to 1 ppm for 45 years is 2.05. In another 
significant cohort (Hayes et al., 1997), the risk ratio (RR) of acute non-lymphocytic 
leukaemia (ANLL) due to an exposure level of 40 ppm-years was 1.9, 4.3 at an 
exposure level of 40–99 ppm-years, and 3.6 at exposure of over 100 ppm-years. 
The respective numbers for ANLL and MDS (myelodysplastic syndrome) were 2.7, 
6.0, and 4.4. It was noted that the risk correlated the best with the last 10 years of 
exposure (Hayes et al., 1997). According to some studies, exposure peaks can be 
significant causes of leukaemia. If an employee has been diagnosed with acute 
myeloid leukaemia, the following criteria have been suggested to support benzene as 
an aetiological factor (Natelson, 2007): 
? Myelodysplastic syndrome 
? Defect in chromosome 5 or 7  
? Exposure history in which the cumulative dose can be estimated to be at 
least 40 ppm-years during the last 10 years  
? Poor response to chemotherapy. 
It should be noted that the occurrence of acute myeloid leukaemia (AML) increases 
significantly among older age groups and that these cancers can include 
chromosome defects that are similar to those found with leukaemia related to 
benzene exposure among younger people.  
In Finland, the highest exposures to benzene in the 2000’s were detected primarily in 
automotive maintenance and installation work, as well as in oil refinery work. In 
general, excluding individual measurements, these exposures have been clearly 
lower than the set exposure limit for air (1 ppm = 3.25 mg/m3) for benzene and the 
related limit set for biomonitoring measurements (14 µmol/l, concentration in urine). 
In the 83 measurements carried out in 2004–2007 by the Finnish Institute of 
Occupational Health (FIOH), the mean value was 0.09 mg/m3, and 95% of the 
measurements were below 0.96 mg/m3. On this basis, it is safe to say that the 
current risk of leukaemia due to exposure to benzene in Finland is very low. In an 
occupation-specific follow-up of cancer morbidity, the risk of leukaemia among car 
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mechanics in the Nordic countries was similar to the risk of other groups of 
professionals (NOCCA, 2012). 
Summary: When the level of exposure to benzene in Finland during the last 10–20 
years is taken into account, occupational cancers caused by benzene are improbable. 
In individual cases, however, if sufficient exposure can be shown (40 ppm-years 
during the last 10 years), occupational cancer is a possibility for a patient with acute 
myeloid leukaemia (AML). 
4.3.5 Nickel 
IARC has classified nickel compounds as being carcinogenic in humans (Group 1). 
Nickel metal and its alloys, on the other hand, have been classified into cancer Group 
2B (possibly carcinogenic in humans). In the EU, metallic nickel and nickel carbonyl 
have been classified as belonging to Category 2 (H351), and nickel compounds are 
found in the cancer category of 1A (H350i). The evidence on the carcinogenic effects 
is the strongest for soluble nickel compounds, but also for nickel oxide and nickel 
sulphide. These nickel compounds have been found to be associated with both lung 
and nasal cancer. 
4.3.5.1 Lung cancer 
Andersen et al. (1996) noted a relationship between cumulative exposure to nickel 
and the risk of lung cancer. A cumulative exposure of more than 15 mg/m3 x year to 
a concentration of soluble nickel increased the risk to RR 3.1 (Table 5). A similar, yet 
weaker trend was also noted for exposure to nickel oxide (low soluble). At the 
highest levels of exposure, the risk ratio increased to 1.5–1.6 (IARC, 2012a). 
 
Table 5. Relationship between lung cancer incidence and cumulative exposure to 
soluble nickela (Andersen et al., 1996; SCOEL, 2011b; IARC, 2012a). 
Exposure level 
(mg/m3) x year 
Mean exposure 
(mg/m3) x year 
Number of lung 
cancers (n) 
RRb  
 
95 % CI 
< 1   0.1 86 1.0 ? 
1?4   2.3 36 1.2 0.8?1.9 
5?14   8.8 23 1.6 1.0?2.8 
> 15 28.9 55 3.1 2.1?4.8 
a Nickel compounds could not be specified. 
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b Controlled for smoking, age, and nickel oxide exposure. 
 
In Finland, exposure to nickel compounds occurs especially in the electrolytic 
enrichment of nickel, as well as during the welding and machining of stainless, acid-
proof, or special steel (Vainio et al., 2005). In measurements carried out by the 
Finnish Institute of Occupational Health (FIOH), the median nickel content in air was 
0.005 mg/m3 for the years 1994–1998 (n=335, mean = 0.21 mg/m3, maximum = 
55 mg/m3), 0.008 mg/m3 for the years 1999–2003 (n=213, mean = 0.06 mg/m3, 
maximum = 2.7 mg/m3), and 0.005 mg/m3 for the years 2004–2007 (n=347, mean 
= 0.04, maximum = 2.7 mg/m3) (Heikkilä and Saalo, 2005; Saalo et al., 2010). The 
current occupational exposure limit for nickel compounds (0.1 mg/m3) was exceeded 
during these years in 7%–9% of the measured samples (Saalo et al., 2010). Process 
measurements of nickel compound manufacturing are not included in the FIOH 
measurements. A high nickel concentration has been detected in, for example, steel 
machining, metal spraying, metal casting, and grinding and coating. In a study 
carried out in 1997 on the electrolytic cleaning of nickel, the concentrations of nickel 
compounds were lower than 0.04 mg/m3 in samples collected from the inside of a 
respirator (Kiilunen et al., 1997).  
In a cohort study by Grimsrud et al. (2003), similar risks of lung cancer were 
detected both among nickel electrolysis workers who had been exposed to nickel 
sulphate before 1953 and among those who were exposed to nickel chloride after 
1953 (SIR=5.5 for employees exposed before 1953 and SIR=4.4 for employees 
exposed after 1953). Significant increases in risk ratios were also detected for other 
nickel enrichment occupations (SIR 3.3–7.0, depending on occupation). It has also 
been noted that exposure to poorly soluble nickel compounds (nickel sub-sulphide 
and nickel oxide) increased the risk of lung cancer (Doll, 1990). In a Finnish study 
(Anttila et al., 1998), it was found that, for nickel enrichment (exposure to soluble 
nickel sulphate), the risk of lung cancer was 2.61 for the entire cohort. When the risk 
of cancer was studied with a latency period of more than 20 years, risk was even 
higher (SIR=3.38). The average concentration of soluble nickel in the air was 0.25 
mg/m3. Similarly, a clearly elevated risk of lung cancer (SIR=2.00) was noted for 
smelters after a latency period of more than 20 years. 
WHO has estimated that the unit risk factor for nickel-related lung cancer is 3.8 x 10–
4 µg/m3. According to this value, it can be calculated that, when an employee is 
exposed to nickel compounds (different mixtures of nickel compounds) for his or her 
entire career, at the current occupational exposure limit for nickel of 0.1 mg/m3, 3 
excessive lung cancers are caused for every 1000 exposed employees (3×10-3). 
When the concentration is 0.01 mg/m3, 3 excessive cancers occur for every 10 000 
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exposed employees (3×10-4), and, when the concentration is 0.001 mg/m3, 3 
excessive cancers are caused for every 100 000 exposed employees (3×10-5). This 
estimate is based on the assumption that the dose–response ratio is linear. There 
are, however, different views about the form of the dose–response ratio at low levels 
of exposure. For example, the opinion of the Scientific Committee on Occupational 
Exposure Limits (SCOEL) is that, on the basis of mechanistic information, there is no 
risk of cancer when a person is exposed to concentrations of less than 0.01 mg/m3. 
Summary: There is convincing evidence that exposure to nickel compounds is related 
to lung cancer, but information about the dose–response ratios is inadequate. When 
the cumulative exposure level increases to more than 2 mg/m3, the risk ratios may 
become significant. The evidence on dose–response ratios is the most conclusive 
concerning soluble nickel, but also low soluble nickel compounds clearly cause 
cancer. There is no epidemiological evidence about the carcinogenicity of metallic 
nickel. 
4.3.5.2 Sinonasal carcinoma  
IARC has evaluated the association between exposure to nickel and sinonasal 
carcinoma. It states that an increased risk of sinonasal carcinoma is connected with 
nickel refining, but not with smeltering (unlike the case for lung cancer). The risks 
are the highest for soluble nickel. There is also independent evidence concerning the 
risks caused by nickel sulphates and nickel oxides. 
In the literature on pathology, exposure to nickel has been found to be associated 
with squamous cell carcinoma cases. There were no references to histology in the 
reviewed epidemiological studies. 
Most of the information regarding exposure levels can be found in a 1996 publication 
by Andersen et al., which concentrates on nickel refinery workers. In their research, 
nickel oxide and soluble nickel compounds were studied separately. A dose–response 
ratio was identified for both, and nickel oxide was noted to cause a higher risk of 
sinonasal carcinoma than soluble nickel did. Twelve cases of sinonasal carcinoma 
were diagnosed among employees who had been primarily exposed to nickel oxide 
(>15 mg/m3, SIR 44.7). Other exposures were various mixed exposures. For the 
employees exposed only to soluble nickel, the SIR was 2.7 (95% CI 0.3–9.8) on the 
basis of two cases. When the nickel oxide concentration was 1–4 mg/m3 x year, the 
SIR for the entire soluble group (the highest category being more than 15 mg/m3 x 
year) was 14.3 (95% CI 5.2–31.2). All of the cases of sinonasal carcinoma were 
diagnosed for people who had been employed before 1956. Thereafter, the risk of 
sinonasal carcinoma decreased. 
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In 1998, Järup et al. studied battery workers who were exposed to nickel hydroxide 
and cadmium oxide. Two of the sinonasal carcinoma cases occurred at a nickel 
exposure level of more than 2 mg/m3, and one occurred at an even lower level. 
In a Finnish study carried out in a nickel refinery, 2 cases were detected when only a 
level of 0.04 cases was expected (Anttila et al., 1998).  
Summary: There is clearly an elevated risk of sinonasal carcinoma related to nickel 
refinery work. The exposure level of about 1 mg/m3 x year can be regarded as an 
indicating limit. On the other hand, also the diagnosis should be noted; sinonasal 
carcinoma is a relatively rare tumour whose occurrence is significantly affected by 
exposure to nickel. On this basis, the link between nickel refinery work and sinonasal 
carcinoma can be considered sufficient. The EU (EC, 2009) proposes 6 months as the 
minimum duration of exposure and 15 years as the induction period. Even though 
the evidence is the most compelling for nickel refinery work, it can be assumed that 
similar exposure in other occupations can also cause an elevated risk of sinonasal 
carcinoma. 
4.3.6 Chromium (VI) 
IARC has classified hexavalent (VI) chromium as carcinogenic in humans (Group 1). 
In the EU, it has been classified into cancer Category 1A (H350) according to the 
CLP. There is sufficient evidence showing an association between exposure to 
chromium (VI) and lung cancer (IARC, 2012a). In addition, some cohort and case-
control studies propose that exposure to chromium (VI) could also be linked to 
sinonasal carcinoma. According to the evaluation by IARC, these results are difficult 
to assess because, for example, of possible bias mechanisms (IARC, 2012a).  
The most compelling evidence for an increased risk of lung cancer exists for the 
manufacturing of chromates and chromate pigments. The dose–response has been 
researched in two cohort studies published in the early 2000’s concerning chromate 
manufacturing. In the study by Gibb et al. (2000), the relative risk for all employees 
exposed to chromium (VI) was 1.8, but when the cumulative exposure level was 
0.077–5.25 mg/m3 x year, the relative risk increased to 2.24. In the study carried 
out by Luippold et al. (2003), the relative risk (SMR) for all employees exposed to 
chromium (VI) for an average of 1.58 mg/m3 x year chromium (VI) was 2.41. For 
the most exposed group of employees (2.70–23 mg/m3 x year) the risk was 4.63, 
whereas, for the second most exposed group (1.05–2.69 mg/m3 x year), the SMR 
was 3.65 (95 % CI 2.08–5.92) (IARC, 2012a).  
On basis of epidemiological research, SCOEL (2004a) has estimated that the 
calculated risk of cancer related to exposure to chromium (VI) is 0.5–3 excessive 
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cases of lung cancer for every 10 000 exposed people at an exposure level of 0.005 
mg/m3. According to the SCOEL calculations, exposure to a chromium (IV) 
concentration of 0.02 mg/m3, corresponding to the current occupational exposure 
limit (0.05 mg/m3), causes 2–11 excessive deaths because of cancer for every 1000 
exposed employees.  
In Finland, the workers with the highest exposure to hexavalent chromium are 
welders and platers, machinists, gas cutters, and construction workers. In addition, 
metal coating work, wood impregnation, and chromate pigment handling may 
expose employees to hexavalent chromium. The exposure of welders to chromium 
(VI) is described in Section 5.3.7, which concerns welding fumes. According to 
measurements carried out in 1994–2003 by the Finnish Institute of Occupational 
Health (FIOH), the concentration of chromium (VI) in the workplace air was usually 
below 0.005 mg/m3 at chrome-plating facilities in which baths containing chromium 
(VI) compounds are used (Työterveyslaitos, 2007a). The levels detected in all of the 
chromium (VI) measurements carried out by FIOH in 1994–2007 remained relatively 
constant. The median, mean, and maximum values of these measurements were as 
follows: 0.001, 0.007, and 0.32 mg/m3, respectively, in 1994–1998; 0.002, 0.003, 
and 0.063 mg/m3, respectively, in 1999–2003; and 0.001, 0.007, and 0.21 mg/m3, 
respectively in 2004–2007 (Saalo et al., 2010). 
Summary: Exposure to chromate compounds has been identified as a cause of lung 
cancer. There is, however, little information about the dose–response ratios. The 
widespread nature of lung cancer and other factors increasing the risk of lung cancer 
make the assessment of the occupational background of cancer difficult on an 
individual level. Therefore, every suspected case of occupational cancer caused by 
chromium (VI) compounds must be considered individually, and the level of 
exposure must be taken into account. An exposure level of 1 mg/m3 x year can be 
considered the lower limit for high exposure in relation to lung cancer. Some data 
suggest a relationship between exposure to chromium (VI) and sinonasal carcinoma, 
but it is difficult to assess the results of existing research because of, for example, 
possible publication bias. There is no evidence for the carcinogenicity of metallic 
chromium or trivalent chromium. 
4.3.7 Welding fumes 
The welding of stainless steel can expose employees to carcinogenic hexavalent 
chromium and nickel. In 1990, IARC classified welding fumes as possibly 
carcinogenic in humans (Group 2B). This assessment was based on epidemiological 
research that indicated an increase of about 30%–50% in the risk of lung cancer 
among welders.  
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In 2001, Nurminen and Karjalainen estimated that 1.6% of the lung cancers 
occurring among men and 0.1% of those occurring among women could be caused 
by exposure to chromium (VI) compounds during welding. These values would 
correspond to 25–30 cases of cancer in Finland annually. The evaluation was based 
on the risk ratio of 1.4 derived from a study by Droste (1999). Ambroise et al. 
(2006) carried out a comprehensive meta-analysis containing 60 epidemiological 
studies published in 1954-2004, in which it was noted that the risk of lung cancer 
among welders was elevated by 26% (RR 1.26, 95% CI 1.21–1.32). Sørensen et al. 
(2007) found that the risk of lung cancer among a cohort of 4539 welders was 
elevated by 35%. Among welders of stainless steel (but not of non-alloyed steel), the 
risk correlated with the duration of exposure. The mean total fume exposure was 1.6 
mg/m3 for the welders of stainless steel and 3.0 mg/m3 for those welding non-
alloyed steel. For the employees primarily using manual metal arc welding, the risk 
was higher than for those using other methods (SIR 1.46 vs. SIR 0.72). Manual 
metal arc welding exposes employees to chromium (VI) more than other ordinary 
welding techniques do. In the Nordic NOCCA research project, the risk of lung cancer 
among male welders was found to be SIR = 1.33 (NOCCA, 2012).  
Information about exposure to welding fumes based on measurements carried out 
by the Finnish Institute of Occupation Health (FIOH) has been combined in the FIOH 
memorandum on the target levels concerning welding fumes (Anttila et al., 2011). In 
1994–1998 and 1999–2003, the average total exposure to welding fumes was 
higher than 5 mg/m3, whereas, in 2004–2007, the mean was 2.4 mg/m3 (n=54). 
The nickel concentrations measured during the welding of stainless steel have 
typically varied between 0.004 and 0.063 mg/m3 (soluble nickel <0.001–0.031 
mg/m3) (Työterveyslaitos, 2007b). In the measurements carried out by FIOH, the 
total chromium concentration in air during stainless steel welding has varied between 
0.005 and 0.19 mg/m3 (Työterveyslaitos, 2007b). Of this concentration, soluble 
hexavalent chromium has accounted for less than 0.001–0.14 mg/m3 depending on 
the welding technique. In manual metal arc welding, the percentage of hexavalent 
chromium is the highest; almost all of the chromium can be in the hexavalent form.  
The primary health-related component of non-alloyed steel is manganese, which is 
not carcinogenic. 
Summary: Although the association between exposure to welding fumes and lung 
cancer has been shown in several epidemiological studies, the risk ratios have been 
relatively low (RR < 1.5). The risk is affected by both the welded material and the 
welding process. The manual metal arc welding of stainless steel exposes employees 
to the largest amounts of hexavalent chromium, and therefore the risk associated 
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with it is probably the highest. The welding of aluminium or non-alloyed steel does 
not expose employees to carcinogenic chromium (VI) or nickel compounds.  
4.3.8 Cadmium 
In 1993, IARC classified cadmium as carcinogenic in humans (Group 1) on the basis 
of published research data on cadmium recovery, nickel-cadmium battery 
manufacturing, and cadmium refinement. These research data indicate a statistically 
significant increased risk of lung cancer. The classification was later criticised because 
the early studies contained defects in their control of confounding factors. In the EU, 
cadmium compounds have primarily been classified into cancer Category 1B (H350) 
according to the CLP. 
Three new cohort studies have been published since then. Two of them found an 
association between cadmium and lung cancer, but no clear dose–response relations 
were detected (Järup et al., 1998; Sorahan and Esmen, 2004). One study found a 
relationship between lung cancer and the cumulative exposure to cadmium and 
arsenic, but not between lung cancer and cadmium exposure alone (Sorahan & 
Lancashire, 1997). In the study by Sorahan and Esmen (2004), on the 
manufacturing of nickel-cadmium batteries in Great Britain, no clear relation was 
found between cadmium exposure and lung cancer. In the study by Järup et al. 
(1998) on the manufacturing of nickel-cadmium batteries in Sweden, a risk ratio of 
1.76 was determined on the basis of 16 cases of lung cancer. In 2009, IARC verified 
its classification of cadmium and its compounds and placed it in Group 1. The Finnish 
Institute of Occupational Health has gathered biomonitoring data about cadmium 
exposure in Finland since 1974. In these statistics, from the 1970’s to the 2000’s, the 
average concentration of cadmium in urine had decreased to less than one-fourth its 
previous levels. Tin-cadmium solderers have traditionally been the most exposed 
group of employees. 
Summary: There are many uncertainties connected with the risk of lung cancer in 
relation to exposure to cadmium compounds. Exposure to cadmium in Finland has 
decreased significantly during the last 40 years. 
4.3.9 Cobalt and hard metal 
IARC has classified cobalt and its inorganic compounds as being possibly carcinogenic 
in humans (Group 2B) (IARC, 1991). In the EU, cobalt chloride and cobalt sulphate 
have been classified into cancer Category 1B (H351) according to the CLP. IARC has 
stated that there is limited evidence on the carcinogenicity of metallic cobalt in hard 
metals in humans and inadequate evidence about the carcinogenicity of metallic 
cobalt in humans.  
 Memorandum from the Occupational Cancer Working Group 
 
? 62 
The data on the carcinogenicity of soluble cobalt salts have been obtained in animal 
testing. Cobalt sulphate caused lung tumours in mice and rats in a 2-year cancer 
study (Bucher et al., 1999). The epidemiological data on the carcinogenicity of cobalt 
compounds are inadequate, but increased lung cancer mortality has been detected in 
the hard metal industry. Moulin et al. (1998) carried out a comprehensive cohort 
study including 10 hard metal factories; the study investigated lung cancer mortality 
among employees exposed to hard metal. The study determined a SMR of 1.30. Wild 
et al. (2000) repeated the study on the largest hard metal factories included in 
Moulin’s research and determined a SMR of 1.70 for male employees exposed to 
hard metal. In the highest exposure category, the SMR was 2.02 (95% CI 1.32–
2.96). 
In the workplace air measurements carried out by the Finnish Institute of 
Occupational Health (FIOH) in 1994–1998, the average cobalt concentration was 
0.095 mg/m3, and, in 1999–2003, it was 0.084 mg/m3. High concentrations 
(exceeding the current occupational exposure limit of 0.05 mg/m3) were measured, 
for example, in metal product manufacturing, tool grinding, metal spraying, special 
glass melting, and spray painting (Heikkilä & Saalo, 2005). The manufacturers of 
hard metal powder and stellite drill bits are among the employee groups most 
exposed to cobalt (Vainio et al., 2005). In the grinding of hard metal or stellite drill 
bits, average concentrations of 0.002–0.24 mg/m3 were measured in the 1990’s. The 
concentrations had decreased since the 1980’s (Vainio et al., 2005). 
Summary: Information about the carcinogenicity of cobalt compounds has primarily 
been gathered from animal testing. Because the epidemiological evidence is 
inadequate, it is difficult to prove that a cancer has been caused by exposure to 
cobalt compounds. An elevated risk of lung cancer has been found to be associated 
with exposure to hard metal, but the evidence is still limited. The risk ratios between 
lung cancer and exposure to hard metal were 1.3–2 in two recent studies. 
4.3.10 Arsenic 
IARC has classified arsenic and its inorganic compounds as carcinogenic in humans 
(Group 1). In the EU, arsenic acid, arsenic trioxide, and arsenic oxide have been 
classified into cancer Category 1A (H350) according to the CLP. 
In epidemiological studies among copper smelters, occupational inhalation exposure 
has been found to increase the risk of lung cancer. Most epidemiological cohort 
studies indicate about a 2 to 3 times increased risk in comparison with the risk of an 
unexposed population (IARC, 2012a). The risk has been noted to increase when the 
cumulative exposure level is 0.75 mg/m3 x year or higher. Exposure through drinking 
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water has been found to have caused skin and bladder cancer, and possibly kidney 
cancer, in addition to lung cancer, but there is no evidence of an association with 
occupational exposure (IPCS 2001, IARC 2012a). 
In Finland, employees can be exposed to arsenic, for example, in metal 
manufacturing (copper manufacturing) and the electronics industry. In addition, 
wood impregnation with preservatives comprised of chromium copper arsenate (CCA) 
and the handling of impregnated wood that have previously exposed employees to 
arsenic (CCA) preservatives have been banned since 2003). Significant exposure can 
also occur during the disposal of hazardous waste, the moving of land masses 
contaminated with arsenic, and the handling and manufacturing of arsenic alloyed 
components in the electronics industry (Vainio et al., 2005). By 2002, about 900 
workers had been reported to the ASA register as having been exposed to arsenic. 
The number of reported cases has since increased annually and is now about 1300 
cases per year.  
Summary: Arsenic has been confirmed to be carcinogenic in humans. If long-term 
exposure to arsenic can be shown when the cumulative exposure levels are 0.75 
mg/m3 x year or more, there is a possibility of occupational cancer. 
4.3.11 Wood dust  
IARC has evaluated the association between wood dust and different types of cancer. 
According to IARC, there is sufficient evidence on the carcinogenicity of wood dust in 
humans (IARC Group 1), and it has been noted to cause sinonasal carcinoma and 
nasal cavity cancer. 
4.3.11.1 Sinonasal carcinoma 
In a combined review of 12 case-control studies (Demers et al., 1995b), evidence 
has been found for a dose–response for adenocarcinomas among men [OR 0.6, 95% 
CI 0.6–4.7 at low exposure levels (<1 mg/m3); OR 3.1 (95% CI 1.6–6.1) at 
moderate exposure levels (1–5 mg/m3); and OR 45.5 (95% CI 28.3–72.9) at high 
exposure levels (>5 mg/m3)]. There were few cases among women, but two 
adenocarcinomas were detected at low exposure levels (OR 7.7). There was no clear 
evidence with respect to the situation with squamous cell carcinoma. The risks were 
elevated for furniture makers, carpenters, other wood workers, and sawmill workers. 
Less than a 5-year exposure period was sufficient to cause adenocarcinoma (OR 7.3 
any wood exposed jobs). There was no additional risk detected for a latency period 
of less than 20 years from the beginning of employment (OR 1.0).  
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The findings of the Nordic NOCCA research project were similar to the 
aforementioned results. Even at low exposure levels, an OR of 3 was detected for 
adenocarcinoma. For the purposes of this working group, an attempt was made to 
identify the level of cumulative exposure increasing the hazard ratio (HR) of 
sinonasal-adenocarcinoma to 2. This analysis proved difficult, because there were 
few incidents at low exposure levels and the HR was not linear. The best estimate 
was that level would be 3.5–4 mg/m3 x year. According to the job-exposure matrix 
used in the NOCCA research and the exposure levels estimated for 1960–1984 , this 
exposure level is reached in less than 3 years among sawmill workers and in less 
than 1 year among wood machinery operators. A relatively low level of exposure 
seems therefore sufficient to increase the HR to 2. It must also be noted that the 
incidents in this material were from the Nordic countries (Norway, Sweden, Finland, 
and Iceland) and the exposure was to mixed saw dust. Because of its strong 
association with exposure, this result may emphasise the relevance of tumour type 
when the occupational aetiology of a disease being considered. 
Adenocarcinoma has been widely associated especially with exposure to hardwood 
saw dust (Leclerc et al., 1994). In four studies (Nordic countries, United States, 
Canada, and France), an association between softwood exposure and primarily 
squamous cell carcinoma has been detected (OR 3.3–1.7). In the aforementioned 
NOCCA research project, exposure to saw dust did not increase the risk of squamous 
cell carcinoma. On the other hand, in a recent study among Finnish patients (Siew et 
al., 2012), the RR for squamous cell carcinoma was 1.98. 
Summary: The risk ratios for adenocarcinomas are high and become significant even 
at low exposure levels. The minimum level of significant exposure is difficult to 
define. It is worth noting that IARC currently refers simply to hardwood and softwood 
exposure, whereas earlier references were especially to oak and beech trees. 
According to IARC, it is impossible to separate the effects of individual wood types. 
The situation for squamous cell carcinomas is unclear. Increased risks have been 
detected in some studies but not in others. In any case, the risk ratios are low. 
According to a statement by the EU (EC, 2009), the lowest intensity of exposure 
required is unknown. In this statement, the minimum exposure period was 
considered to be 10 years, whereas 20 years was considered the maximum latency 
period. The statement mentions exposure to softwood, especially oak and beech, 
which also affects the compensation criteria in some countries. 
4.3.11.2 Nasal cavity cancer 
IARC evaluated 9 case-control studies in 1995. An increased risk was detected in 
most of these studies in occupations related to saw dust exposure (4/5) or the 
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handling of wood (3/4). The studies had been carried out in several countries, and 
the OR was 1.5–2.5. 
In three of these case-control studies, which took into account smoking and alcohol 
use, the OR values were 4.1–4.5. Vaughan (1989) and Vaughan and Davis (1991) 
noted an increased risk for carpenters (OR 4.5) and for all employees who had 
worked with wood for over 10 years (OR 4.2). Sriamporn et al. (1992) found an 
increased risk for lumberjacks (OR 4.1).  
Since then, two new cohort studies or an update of a previous cohort study has been 
carried out. Demers et al. (1995a) published a review of five previous cohort studies; 
it determined a SMR of 2.4 (95% CI 1.1–4.5) for people with confirmed exposure.  
In the last three case-control studies, the OR varied from 1.2 to 2.4 (Armstrong et 
al., 2000; Vaughan et al., 2000; Hildesheim et al., 2001). These studies do not 
contain any information about the type of wood. The results remained the same 
when the effect of formaldehyde was controlled. It is worth mentioning that, among 
people of Chinese origin, there is a genetic propensity towards nasal cavity cancer 
that is probably also affected by environmental factors. 
Summary: The risk ratios related to nasal cavity cancer are not as high as for 
sinonasal carcinoma, but an association has nevertheless been found in 
epidemiological studies. However, if clear, long-lasting exposure can be 
demonstrated, occupational cancer should be considered possible. 
4.3.12 Formaldehyde  
IARC has estimated that formaldehyde causes nasal cavity cancer and that there is 
causality between leukaemia and exposure to formaldehyde. IARC also estimates 
that there is limited evidence that formaldehyde causes sinonasal carcinoma. In the 
EU, formaldehyde has been classified into cancer Category 1B (H350) according to 
the CLP. 
4.3.12.1 Nasal cavity cancer 
In the most recent published review of the largest cohort study in the United States 
among employees exposed to formaldehyde (Hauptmann et al., 2004), the SMR was 
2.10 (95% CI 1.05–4.21). The latency period was 15 years. The average exposure 
level was 0.45 ppm (as a time-weighted 8-hour average), and the exposure was 
greater than 2 for 2.6% of the exposed persons. The relative risk (RR) caused by 
cumulative exposure of 1.5–5.5 ppm-years was 1.19, and with a cumulative 
exposure of more than 5.5 ppm-years the risk was 4.14. All of the cancer cases were 
found to be associated with peak exposure levels of over 4 ppm. This study has been 
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criticised because most of the cancer cases occurred in a single factory. A statistically 
insignificant increase in risk levels has been detected for embalmers (Hayes et al., 
1990), with a proportional mortality ratio (PMR) of 216. Hansen and Olsen (1995) 
researched industries producing or using formaldehyde in Denmark and found a 
relative risk (RR) of 3.0 (95% CI 1.4–5.7) for nasal cavity cancer. 
Altogether 5 of 7 case-control studies have indicated an increased risk of nasal cavity 
cancer. In one of them (Vaughan et al., 2000) the OR was 2.1 for the most-exposed 
group. The effect was emphasised for differentiated squamous cell carcinomas (OR 
2.5), as well as for the epithelial NOS group (OR 4.2). For non-differentiated and 
non-keratinised cancers, the OR was 1.5. In the highest categories, an association 
between cumulative exposure (in excess of 1.10 ppm-years) and the duration of 
exposure (more than 18 years) was detected.  
In meta-analyses, the OR values have been on the level of 1.3 (Collins et al., 1997). 
In a combination of three cohorts (including Hauptmann et al., 2004), the SMR was 
1.33. A recently published meta-analysis (Bachand et al., 2010), which included both 
cohort and case-control studies, determined an OR of 1.22 for the case-control 
studies. For the cohort studies the risk was 0.72. 
In Finland, significant exposure, even exceeding the occupational exposure limit (0.3 
ppm), has been measured in resin and glue manufacturing, coating, plywood and 
chipboard manufacturing, histology and pathology laboratory work, and during 
autopsies. 
Summary: For exposure to formaldehyde, a relatively low increase in the risk of 
nasal cavity cancer has been found. The best quantitative exposure information is 
related to studies that have been criticised for concentrating on one single factory. 
The EU (2009) states that the risks are related to exposures causing severe irritation 
(i.e., inflammation). The mentioned limit value is 0.3 ppm. Special attention should 
be paid to extremely high concentrations, which can cause irritation. 
4.3.12.2 Leukaemia 
Excess mortality has been detected in cohort studies in occupations in which 
formaldehyde is used for tissue fixation, for example, in embalming, pathology 
laboratories or faculties of anatomy. There is almost no quantitative information 
about exposure, and therefore funeral home employees have been studied especially 
in association with embalming (Hauptmann et al., 2009). When a control group was 
formed of employees who carried out 500 or fewer embalming procedures, the OR 
was 3.4.  
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When divided according to the average formaldehyde concentration, cancers were 
placed rather equally into different concentration groups. With respect to cumulative 
exposure, the OR was 1.3 or less for employees exposed for 4058 ppm-hours (1950 
ppm-hours = 1 ppm-year), 1.9 for employees exposed for 4058–9253 ppm-hours, 
and 3.2 for employees exposed to higher concentrations. For employees whose 
career had lasted for fewer than 20 years, the OR was 0.4. The findings have been 
less clear for factory workers, but some evidence has been obtained (Beane Freeman 
et al., 2009; Hauptmann, 2003). It seems that the risks were at their highest before 
the year 1980. 
Three case–control studies have been carried out, but the number of exposed 
employees has been small, and no significant increases in the risk levels have been 
noted. 
In a meta-analysis (Collins & Lineker, 2004), the greatest risk ratios were 
determined for embalmers (1.6). In the report by Bosetti et al. (2008), the RR for 
factory workers was 0.9 and that for other professionals was 1.39. Bachand’s study 
(2010) showed the risk of leukaemia to be 1.05 among employees who had been 
exposed during their careers. In their research, Zhang et al. (2009) included only 
studies in which exposure was undeniable, and they also used the group with the 
most exposure to calculate the risk ratio. Their results were an RR of 1.54 for 
leukaemia and an RR of 1.9 for myeloid leukaemia.  
Summary: A risk of leukaemia has been detected especially in association with the 
use of formalin in tissue fixation. The evidence is less clear for industrial practices. 
According to results obtained for embalmers, the OR increases beyond 2 after an 
estimated exposure of about 2 ppm-years. The EU does not consider the association 
between formaldehyde and leukaemia to be firmly established. In Finland, 
concentrations exceeding the occupational exposure limit (0.3 ppm) have been 
measured in departments of pathology during autopsies and in laboratories. 
4.3.12.3 Sinonasal carcinoma 
In an analysis of 12 case-control studies (Luce et al., 2002), an association between 
exposure to formaldehyde and squamous cell cancers was found for the group of 
employees with the highest exposure (>1 ppm), an OR of 2.5 for the men and an OR 
of 3.5 for the women. For adenocarcinoma, the risk for the men was 3.0 and that for 
the women was 6.2. In this case, exposure to saw dust was a confounding factor; 
only 18 cases of 627 had been exposed to formaldehyde only. 
In different cohort studies among employees who have not been exposed to saw 
dust in addition to formaldehyde (embalmers, pathologists, and chemical factory 
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employees), no indications of increased mortality due to sinonasal carcinoma have 
been detected. 
Summary: No clear association between sinonasal carcinoma and exposure to 
formaldehyde has been found in epidemiological studies. 
4.3.13 Strong (sulphuric) acid fumes 
IARC has classified sulphuric acid fumes and other strong acid fumes as carcinogenic 
in humans (IARC Group 1). The classification is based on positive cohort studies in, 
for example, the metal industry, where exposure to strong acid fumes has been high 
during metal pickling tasks, as well as on case-control studies that have supported 
the association between exposure to sulphuric acid fumes and laryngeal cancer.  
In Steenland’s cohort (Steenland et al., 1988; Steenland, 1997) of metal industry 
employees (metal pickling), an RR of 2.3 was detected for laryngeal cancer in the 
study of 1988. In the follow-up of 1997, the RR was 2.2. The exposure period in this 
cohort was about 10 years, and the exposure level was approximately 0.19 mg/m3 
(in inhaled air, IARC, 2012c, vol 100F). It was suggested that exposure peaks had an 
effect on the formation of cancer.  
In Finland, the occupational exposure limit for sulphuric acid is 0.2 mg/m3. According 
to measurements carried out by the Finnish Institute of Occupational Health (FIOH) 
in 2004–2007 (n=87), the average level was 0.05 mg/m3, but, in 40% of the 
measurements, the air concentrations were 10%–100% of the occupational 
exposure limit, and in 7% it was over 100% of the limit.  
Summary: An association between laryngeal cancer and exposure to (sulphuric) acid 
fumes has been found for occupations in which the exposure levels have been high. 
Especially exposure peaks have been suggested to influence the risk of cancer.  
4.3.14 Cytostatic drugs  
Several chemotherapy drugs are known to be genotoxic. When protection has been 
insufficient, chromosome damage in peripheral blood lymphocytes or urine 
mutagenicity related to the exposure to cytostatics has been detected among 
employees (Sessink & Bos, 1999). The capability of several chemotherapy drugs to 
cause cancer has been shown either in animal testing or as diagnosed secondary 
cancers such as leukaemia among treated patients. However, epidemiological 
research has not been able to show a clearly increased risk of cancer among nurses 
or pharmacists who have been exposed to cytostatics in their work. In Finland, the 
levels of exposure to chemotherapy drugs among employees in pharmacy and 
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nursing work are low according to a study carried out in the early 2000’s (Hämeilä et 
al., 2003).  
Summary: No increased risk of cancer from exposure to cytostatic drugs has been 
shown by epidemiological research. 
4.3.15 Aromatic amines  
Benzidine, 2-napthylamine, and 4-aminobiphenyl are classic IARC Group 1 
carcinogens causing bladder cancer. Their industrial use has been banned for a long 
time, and it is improbable that cancers caused by these compounds would still be 
diagnosed even though the latency period for bladder cancer can, in some cases, be 
up to 50 years.  
Of the other aromatic amines, methylenebis(2)-chloroaniline (MOCA) is used in the 
plastics and rubber industries, as well as in the manufacturing of certain 
polyurethanes as a hardener. Toluidines (o-, p-, m-toluidines), on the other hand, 
are used primarily as intermediaries in the chemical industry. They are also IARC 
Group 1 carcinogens. The IARC classification of MOCA is based on strong animal test 
evidence, as well as on evidence involving the carcinogenicity mechanisms and 
genotoxicity of MOCA, including DNA adducts and chromosome defects in the blood 
and bladder cells of employees.  
Epidemiological evidence about the risk of cancer is, however, insufficient. In Finland, 
exposure to MOCA is low. There is sufficient evidence showing an association 
between o-toluidine and the induction of bladder cancer. In one American study 
carried out in the chemical industry, a relative risk of 11.1 was detected for 
employees with more than 10 years of exposure to o-toluidine (Ward et al., 1991). 
There is no epidemiological evidence available for p- and m-toluidines. There is no 
exposure data available from Finland. 
Summary: The probability of occupational cancers caused by aromatic amines in 
Finland is very low because of their scarce use in this country. However, if a clear, 
long-lasting exposure to the aforementioned aromatic amines can be shown, 
occupational cancer is a possibility for a patient with bladder cancer. 
4.3.16 Solvents: styrene and chlorinated hydrocarbon 
solvents 
In addition to benzene, also some other ordinary solvents have been suspected to 
have carcinogenic effects. These solvents include styrene, classified into Group 2B by 
IARC (possibly carcinogenic in humans); trichloroethylene and tetrachloroethylene 
(IARC Group 2A, probably carcinogenic in humans); chloroform, carbon tetrachloride, 
 Memorandum from the Occupational Cancer Working Group 
 
? 70 
and methylene chloride (IARC Group 2B). In the EU, styrene has not been classified 
as carcinogenic; trichloroethylene has been classified into cancer Category 1B (H350, 
may cause cancer); and tetrachloroethylene, chloroform, carbon tetrachloride, and 
methylene chloride belong to Category 2 (H351, suspected of causing cancer). 
Evidence on the carcinogenic effects of these solvents is primarily based on animal 
testing. In animal testing, styrene has caused lung tumours in mice, and it is 
suspected to be genotoxic also in humans (EU, 2007). Epidemiological evidence 
about the carcinogenicity of styrene is, however, insufficient, and the relevance of 
the carcinogenicity data gathered from testing with mice is still debated because of 
the differences in the lung metabolism of styrene between mice and men (EU, 2007).  
Animal test evidence on the carcinogenicity of trichloroethylene is convincing. First of 
all, it has caused liver and lung cancers in rodents. Lately, also epidemiological 
evidence has been gathered on the carcinogenicity of trichloroethylene in humans. 
There is especially evidence on the association between trichloroethylene and kidney 
cancer (Scott & Chiu, 2006). In a comprehensive Danish research project, an 
increased risk of kidney cancer correlating with the length of exposure was noted for 
employees in different industries with exposure to trichloroethylene. For women and 
men who had been exposed for more than 5 years, the risk ratio (RR) for cancer was 
1.5 and 1.6, respectively (Raaschou-Nielsen et al., 2003). In a study by Zhao et al. 
(2005), an increased risk ratio correlating with exposure was noted for employees in 
the aerospace industry. For the group with the most exposed employees, the risk 
ratio for kidney cancer was 4.9 (95% CI 1.2–20). An estimate for the related 
cumulative exposure levels was not, however, given. Purdue et al. detected a risk of 
3.3 when exposure exceeded 234 000 ppm-hours (about 137 ppm-years). In their 
review article from 2003, Lohi and Kujala stated that, if a kidney cancer patient has 
been exposed to high concentrations of trichloroethylene through inhalation at work 
for several decades and no other cause of cancer can be identified, the disease can 
be considered an occupational disease. When it comes to liver and bile duct cancers, 
the risk ratios in the study carried out by Raaschou-Nielsen et al. (2003) were 1.1 for 
the men and 2.8 for the women. An increase in risk as the exposure increased was 
not as significant as it was with kidney cancer. There is some epidemiological 
evidence also showing an association between trichloroethylene and non-Hodgkin’s 
lymphoma and leukaemia, but the evidence is not as strong nor as consistent as with 
kidney cancer. In the meta-analysis by Scott and Jinot (2011), the risk for kidney 
cancer in the highest exposure group was 1.58. 
There has also been strong evidence for the carcinogenicity of tetrachloroethylene in 
animal testing. In the tests, tetrachloroethylene caused leukaemia, as well as liver 
and kidney tumours. The epidemiological evidence on the association between 
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tetrachloroethylene and cancer is limited (IARC, 1999; SCOEL, 2008; WHO, 2006). 
In some studies, an increased risk of, for example, kidney cancer, oesophageal 
cancer, and cervical cancer, as well as non-Hodgkin’s lymphoma, has been detected 
for dry cleaning employees (WHO, 2006). Because the widespread use of 
tetrachloroethylene by dry cleaners only began in the 1960’s, the influence of earlier 
exposure levels on the formation of diagnosed cancers cannot be entirely ruled out 
(WHO, 2006).  
In animal testing, methylene chloride has caused cancer in mice. According to 
current knowledge, these cancers are associated with a certain metabolite of 
methylene chloride, produced in larger amounts by mice. There is no epidemiological 
evidence on the carcinogenicity of methylene chloride. In animal testing, large doses 
of chloroform have caused liver and kidney cancers, and carbon tetrachloride has 
caused liver cancers. Neither of these compounds has been shown to be genotoxic, 
and it has been thought that the carcinogenic effects detected in animal testing are 
associated with the general liver and kidney toxicity manifested at large doses. There 
is no epidemiological evidence indicating that these compounds are carcinogenic in 
humans. 
People are exposed to styrene especially in the reinforced plastics industry, where 
high concentrations exceeding the occupational exposure limits are found. In Finland, 
exposure to trichloroethylene occurs especially during grease removal from metals. 
According to measurements carried out by the Finnish Institute of Occupational 
Health in 1994–2003, the concentrations near steam cleaning basins were over 160 
mg/m3 (the old occupational exposure limit for trichloroethylene; the current limit 
being 50 mg/m3) in 12% of the cases and over 80 mg/m3 in 24% (Vainio et al., 
2005). Exposure to tetrachloroethylene is the highest in dry cleaning operations. The 
average exposure levels in the 1990’s and 2000’s have usually been 10%–20% of 
the occupational exposure limit (70 mg/m3). 
Summary: In addition to benzene, there is evidence indicating the carcinogenicity of 
only a few common solvents. For styrene, tetrachloroethylene, chloroform, carbon 
tetrachloride, and methylene chloride, the evidence is based on animal testing, and 
there either is no epidemiological data or the data are insufficient. Because the 
epidemiological evidence is insufficient, it is difficult to prove that a cancer is caused 
by these solvents. With trichloroethylene, there is relatively convincing 
epidemiological evidence, especially for the association of tetrachloroethylene 
exposure with kidney cancers, but the dose–response ratios are uncertain. In one 
study, an exposure of about 137 ppm-years led to a 3.3-fold increase in risk. This 
level would correspond to over 10 years of exposure to concentrations exceeding the 
occupational exposure limit (10 ppm).  
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4.3.17 Vinyl chloride 
IARC has classified vinyl chloride into Group 1 (carcinogenic in humans). Also in the 
EU, vinyl chloride has been classified into Category 1A according to the CLP. 
The capability of vinyl chloride to cause liver cancer, more specifically angiosarcoma 
of the liver, is well known. Preceding liver cancer, hepatocellular hyperplasia and 
fibrosis have been described (Boffeta et al., 2003b). There are also  descriptions of 
specific mutations in the Ki-ras proto-oncogene (G-A transition in codone 13) and 
tumour suppressor protein p53 (A-T transversion), which are associated with liver 
cancer caused by vinyl chloride (Dogliotti, 2006). The risk of cancer caused by vinyl 
chloride is estimated to be 3x104 when the exposure during the entire career of a 
worker exceeds 1 ppm (SCOEL, 2004b). In epidemiological research, the risk ratios 
for liver cancer have been on the level of a SMR of 1.36–57.1 (Boffeta et al., 2003b). 
In some studies the risk has remained elevated even though angiosarcoma of the 
liver has been removed from the analysis with a reference to the fact that the risk of 
other liver cell types has also been slightly elevated [e.g., Ward et al., 2001 (SMR 
1.27); Mundt et al., 2000 (SMR 1.8); Wong et al., 2002 (SMR 1.78) – described in 
Boffeta et al., 2003b]. 
In Finland, exposure to vinyl chloride has primarily occurred in polyvinyl chloride 
(PVC) production. In measurements carried out in the early 1990’s, the average daily 
exposure was 0.1 ppm. Nowadays, PVC is no longer produced from monomers in 
Finland. The vinyl chloride residues in PVC have, in the last few decades, been so low 
that exposure in PVC handling and machining is below the detection limits of the 
measurement method (Vainio et al., 2005). 
Summary: If a patient is diagnosed with angiosarcoma of the liver and long-lasting 
occupational exposure to vinyl chloride can be shown, the cancer can be considered 
to be an occupational disease. 
4.3.18 1,3-butadiene 
IARC has classified 1,3-butadiene into Group 1 (carcinogenic in humans). Also in the 
EU, 1,3-butadiene has been classified as belonging to Category 1A according to the 
CLP. 
The evidence on the carcinogenicity of butadiene has been primarily derived from the 
rubber industry. In a study among nearly 17 000 rubber industry employees, Graff et 
al. (2005) noted that the cumulative exposure to butadiene correlated with an 
increased risk of leukaemia. The relative risk for mortality from leukaemia was 1.4 
when an employee was exposed to butadiene for 0–33.7 ppm-years; 1.2 when the 
exposure level was 33.7–184.7 ppm-years; 2.9 when the exposure level was 184.7–
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425 ppm-years; and 3.7 when the exposure level was 425 ppm-years or more. In 
addition, it seems that peak exposures (momentary exposure to more than 100 
ppm) could be significant from the point of view of cancer risk (Cheng et al., 2007; 
Delzell et al., 2001). 
For the most part, chemical industry process managers, laboratory technicians, and 
chemical process technology specialists have been reported to the ASA register as 
employees exposed to butadiene. The production of styrene-butadiene latex has 
been the main use of butadiene in Finland. Exposure to butadiene was widely studied 
in the late 1990’s in a research project of the Finnish Institute of Occupational 
Health, which concentrated on the production of butadiene and styrene-butadiene 
latex. The exposure levels were low. In 1002 industrial hygiene measurements of 
1,3-butadiene, the occupational exposure limit of 1 ppm was exceeded only 25 
times. Butadiene concentrations in styrene-butadiene latex production were under 
the detection limit (0.013 ppm) in 70% of the measurements. In 27%, the 
concentrations were in the 0.013–1 ppm range, and in 3% they exceeded the 
occupational exposure limit. The maximum values exceeding the exposure limit were 
11–21 ppm, and some of the values in excess of the limit were caused by the hose 
used during the chemical unloading or loading phase becoming unattached. In the 
production of 1,3-butadiene, the concentrations were 0.013–1 ppm in most of the 
samples (69%). Altogether 28% of the samples were below the detection limit, and 
3% exceeded the occupational exposure limit. When the occupational exposure limit 
was exceeded, the concentrations remained under 5 ppm (Vainio et al., 2005). 
Employee or consumer exposure to monomers released from butadiene polymers is 
minimal or non-existent.  
Summary: Exposure to butadiene has been noted to increase the risk of leukaemia. 
In Finland, exposure to butadiene has been low according to studies carried out 
already in the 1990’s. Therefore the probability of butadiene causing leukaemia in 
Finland is supposedly low, but, in principle, if significant cumulative exposure (in 
excess of 180 ppm-years) and high exposure peaks can be shown, occupational 
cancer is a possibility. It should be noted that the latency period of leukaemia is 
usually shorter than that of many other cancers. 
4.3.19 Ethylene oxide 
IARC has classified ethylene oxide into Group 1 (carcinogenic in humans). In the EU, 
it has been classified as belonging to Category 1B according to the CLP. 
In some early epidemiological research, an increased risk of, for example, leukaemia 
has been detected among employees exposed to ethylene oxide, but this finding has 
 Memorandum from the Occupational Cancer Working Group 
 
? 74 
not been verified by later research. So far, in the most comprehensive American 
research project, the average risk of leukaemia was similar to the average risk of the 
entire population. There was, however, a slight dose–response relationship when 
cancer mortality was studied in relation to cumulative exposure. IARC (2008) 
considered the epidemiological evidence on the carcinogenicity of ethylene oxide to 
be limited for humans, and, therefore, the IARC classification is in fact based on both 
animal testing and evidence on the carcinogenic mechanisms and genotoxicity of 
ethylene oxide, including chromosome damage in, for example, peripheral blood 
lymphocytes detected among employees. 
Summary: Employees are exposed to ethylene oxide, for example, in the 
maintenance of hospital equipment. Measurement data from Finland are limited. 
Because the epidemiological evidence is limited, it is difficult to prove that a cancer 
has been caused by ethylene oxide. 
4.3.20 Leather dust 
IARC evaluated the association between leather dust and sinonasal carcinoma in 
1987, when the relationship between nasal adenocarcinoma and the boot and shoe 
industry was noted and the greatest risks were found in occupations with the most 
exposure to leather dust. In a new monograph (IARC 2012a) IARC has stated that 
there is sufficient evidence on the carcinogenicity of leather dust and that leather 
dust causes sinonasal carcinoma. 
A combined analysis of 8 case-control studies (’t Mannetje et al., 1999) found 
evidence of a relationship between sinonasal carcinoma and exposure to leather dust 
(women’s OR 2.7, men’s OR 1.9). In this analysis, the OR for adenocarcinoma was 
3.0, and that for squamous cell cancer was 1.5. In a recent Italian study (d'Errico et 
al., 2009), the OR for adenocarcinoma was as high as 26, and, for squamous cell 
cancer, it was 5 (the result is not significant because it was based on 1 case only). 
With adenocarcinoma, even a low level of exposure for less than 5 years increased 
the risk of cancer.  
In Finland, exposure to leather dust has been measured in shoemaking businesses. 
The dust concentrations have been 0.07–1.0 mg/m3 (Uuksulainen et al., 2002), and 
they contained leather dust, polymers, and finishing agents. In a Polish shoe factory, 
the highest measured dust concentration was 0.9 mg/m3, the highest peak being 
14.6 mg/m3 (Stroszejn-Mrowca & Szadkowska-Stanczyk, 2003). 
Summary: The trouble with the association between leather dust and sinonasal 
carcinoma is that there are few studies investigating leather dust concentrations and 
their relationship with morbidity. According to d'Errico’s et al.’s (2009) research, as 
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well as to other previous research in the shoe industry, the level and possible type of 
exposure may have significant effects. As for the diagnosis, leather dust has a clear 
correlation with the occurrence of adenocarcinoma, similar to that of saw dust. The 
association of leather dust with sinonasal carcinoma is significantly more probable if 
the cancer is adenocarcinoma. 
4.3.21 Ceramic fibres 
IARC has classified ceramic fibres into Group 2B (possibly carcinogenic in humans) 
on the basis of sufficient evidence from animal testing (IARC, 2002).  
Ceramic fibres consist primarily of aluminium silicate. In animal testing, ceramic 
fibres have caused mesothelioma and lung tumours in rats and hamsters. The 
mechanism is thought to be transmitted via chronic irritation. SCOEL (2011a) has, in 
its recent draft of recommendations, stated that a threshold dose can probably be 
identified for these effects and, when exposure levels remain below 0.3 fibres/cm3, 
the risk of cancer is probably non-existent. Epidemiological research has not found 
any association between exposure to ceramic fibres and cancer or lung fibrosis. In 
previous research, high exposure levels have been noted to cause pleural plaques 
among employees. In addition, epidemiological studies have found an association 
between exposure to ceramic fibres and non-malignant pulmonary effects 
(bronchitis, decrease in lung function, irritation). The most important application of 
ceramic fibres is for heat insulation in industrial smelting ovens and kilns (about 30 
tons per year (Vainio et al., 2005). There have been a little more than 100 cases of 
ceramic fibre exposure reported to the ASA register annually, especially from the 
metal industry, metal manufacturing, and the insulation industry. 
Summary: The epidemiological evidence on the causation between cancer and 
exposure to ceramic fibres is inadequate.  
4.3.22 Nanoparticles: carbon nanotubes 
Nanoparticles cannot be addressed as a single entity. The properties (and thus 
carcinogenicity) of nanoparticles are affected both by the properties of the particles 
(biopersistence, size, shape, and agglomeration or aggregation tendency) and the 
material (e.g., different metal nanoparticles).  
Currently, animal testing data on carbon nanotubes indicate that they may cause 
inflammatory lung reactions, including lung granuloma and lung fibrosis via 
inhalation exposure. In addition, there is evidence concerning the genotoxicity of 
carbon nanotubes (NEG, 2013). The carcinogenicity of carbon nanotubes has not 
been studied with inhalation tests, but, in animal testing models in which carbon 
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nanotubes have been introduced intraperitoneally or intrascrotally, they have caused 
mesothelioma. This information, combined with the existing data on genotoxicity, 
suggests that the capability of carbon nanotubes to cause mesothelioma may be 
similar to that of asbestos. No epidemiological evidence is available yet about the 
carcinogenicity of carbon nanotubes.  
The information about exposure to carbon nanotubes in different occupations is also 
inadequate. Even if significant exposure would have occurred in some occupations, 
when the latency period required for the formation of mesothelioma or lung cancer is 
taken into account, it will probably still take several years before this correlation can 
be epidemiologically proven. Therefore, the current risk of cancer caused by carbon 
nanotubes in different occupations cannot yet be estimated. 
Summary: Because epidemiological evidence and exposure data are currently 
inadequate, it is impossible to evaluate the risk of cancer caused by carbon 
nanotubes in different occupations. According to animal testing, carbon nanotubes 
may have effects that are similar to those of asbestos. 
4.4 Physical factors 
4.4.1  Ionising radiation 
Ionising radiation belongs to IARC Group 1 carcinogens. The risk of occupational 
cancer caused by ionising radiation has been studied among health care personnel 
(radiologists and radiographers), nuclear power plant employees, and air crews 
(cosmic radiation). In a study carried out by Cardisin et al. (2005) among nuclear 
power plant employees, it was noted that increased exposure of 1 sievert (1 Sv) 
caused a 1.93 risk ratio for leukaemia. In addition, an association was noted for solid 
tumours, for which the risk ratio was 0.97 per sievert.  
Smoking may explain some of the risk, but scientists have estimated that 1%–2% of 
cancer mortality among these employees may be caused by radiation. In American 
studies carried out among radiologists and radiographers, an increased risk of breast 
cancer was detected among employees who had begun their careers in the 1930’s 
and 1940’s (Mohan et al., 2002), and an increased risk of leukaemia was found for 
those who had been working for over 5 years before 1950 (RR 6.6) (Linet et al., 
2005). In a study carried out among Finnish physicians (Jartti et al., 2006), no 
increase was noted for the risk of cancer. A regression analysis of the cumulative 
dose indicated a statistically non-significant increase in the risk of cancer. The mean 
cumulative exposure was 12.7 mSv, the median being 1 mSv.  
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Altogether 6% of the studied radiologists had been exposed to a cumulative dose in 
excess of 50 mSv. This research proves that the risk of cancer among Finnish 
radiologists is low. Air crews are exposed to average doses of 2 mSv annually. Pilots 
and cabin crews have been shown to have an increased risk of melanoma, which is 
probably related to spending more holidays in the sun. Among female cabin crews 
the detected risk of breast cancer was 1.5-fold, but this rate did not correlate with 
the radiation dose. Therefore, the increase may have been caused by other factors 
(Pukkala et al., 2012). The same studies also noted an increased risk of leukaemia 
among female cabin crews; it did not, however, correlate with the cumulative 
radiation dose (Pukkala et al., 2012).  
Summary: Exposure to radiation is known to cause cancer. Among nuclear power 
plant employees and health care personnel, exposure has been found to be 
associated especially with leukaemia. Among health care professionals, also the risk 
of breast cancer has been elevated among employees whose career began before 
1950. When it comes to the dose–response relationship of radiation, it is known that 
an average occupational exposure of 1000 mSv will double the risk of cancer. The 
dose threshold of occupational radiation is 20 mSv per year. The calculated risk of 
cancer at such an exposure level is 2 cancers in 10 years for every 1000 exposed 
employees. In Finland, the exposure levels of air crews and radiology personnel have 
remained significantly lower during the last few decades (since the 1970’s), at 1 or 2 
mSv per year. It can therefore be assumed that occupational cancer among 
employees who have been exposed to radiation after the 1970’s is improbable. 
Among operating radiologists, the average dose during 5 years may sometimes 
locally exceed 20 mSv per year, which may cause a risk of skin cancer.  
4.4.2 Radon 
Radon belongs to IARC Group 1 carcinogens. Radon in the soil and its daughter 
nuclides emit alpha radiation. Radon is known to cause lung cancer, and it has been 
estimated that the locally high soil radon concentrations in Finland cause about 40 
lung cancers among non-smokers and more than 200 lung cancers in conjunction 
with smoking (Mäkeläinen, 2010).  
It is possible to be significantly exposed to radon in mining work, and an increased 
risk of lung cancer correlating with radon exposure has been detected among mining 
workers. Improved ventilation technology on mine sites has nowadays lowered the 
exposure levels. Because radon is formed during uranium decay, especially the 
mining of uranium ores may expose employees to radon.  
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In some regions, room air may contain radon in excess of the allowed 200 Bq/m3, 
whereas the average concentration is 100 Bq/m3 (Mäkeläinen, 2010; Kurttio, 2010). 
Living for 30 years in a radon concentration of approximately 700 Bq doubles the risk 
of lung cancer by the age of 75 years (Darby et al., 2005). It is usually difficult to 
separate occupational exposure to radon from environmental exposure. 
4.4.3 Ultraviolet radiation  
IARC has classified ultraviolet (UV) radiation from the sun as a Group 1 carcinogen. 
It is known to cause skin cancer: melanoma, squamous cell carcinoma, and basal cell 
carcinoma. It has also been known to cause lip cancer and certain types of eye 
cancer (IARC, 2012d). In a joint Nordic research project by Andersen et al. (1999), 
the risk of skin cancer was not significantly elevated in outdoor occupations in 
Finland. Similarly, in the NOCCA research project, the risk of skin cancer was not 
elevated among outdoor workers (Pukkala et al., 2009). On the other hand, the risk 
of lip cancer was elevated among male fishermen, farmers, gardeners, forestry 
workers, and sailors, but not among women. For these occupations, the SIR was 
primarily below 2 (varying between 1.21 and 2.27). Therefore, although UV radiation 
from the sun is a strong source of exposure also in Finland, the associated risk of 
occupational cancer is probably low.  
4.4.4 Electromagnetic fields  
IARC has classified low-frequency electromagnetic fields as possibly carcinogenic in 
humans (Group 2B) on the basis of epidemiological leukaemia observations among 
children. The discovered association between electromagnetic fields and cancer is, 
however, so weak that, based on these studies, it is difficult to prove that 
electromagnetic fields increase morbidity. Because the evidence is insufficient, it is 
currently not possible to demonstrate that a cancer is caused by exposure to 
electromagnetic fields. Employees who can be exposed to electromagnetic fields 
include, for example, electrical transformer station employees, crack inspectors in 
the metal industry, employees working close to induction devices, and test users of 
electric motors.  
4.5 Biological factors 
Hepatitis B and C may cause an occupational disease if an employee is infected via 
accidental blood exposure. Chronic hepatitis is more commonly caused by hepatitis 
C, for which about 50% of the exposed people remain carriers and 20%–30% of 
them develop chronic active hepatitis, liver cirrhosis, or hepatocellular cancer. This 
scenario is less probable but not impossible with hepatitis B. If an employee has 
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already been diagnosed as a hepatitis B or C carrier and has chronic active hepatitis, 
a possible hepatocellular cancer of that patient is probably also caused by 
occupational exposure. 
Human immunodeficiency virus (HIV) is associated with a propensity for different 
types of cancer. Especially Kaposi’s sarcoma is typical to HIV patients, but also other 
cancers, such as lymphoma, occur. HIV may cause an occupational disease if an 
employee is infected via accidental blood exposure. 
In addition to the viruses discussed in this section, other carcinogenic viruses include, 
for example, the Epstein Barr virus and the human papilloma virus (HPV). 
4.6 Occupations and professions classified by IARC 
IARC has assessed many occupations in which increased cancer morbidity has been 
detected. Some of them have already been described, for example, in the section on 
PAH compounds. Occupations that have been lately presented in this context and 
their related risk of cancer are discussed in the following sections. 
4.6.1 Shift work  
IARC has estimated that shift work, which disturbs the normal circadian rhythm, is 
probably carcinogenic in humans (IARC Group 2A). This classification is based on 
limited evidence from epidemiological studies concentrating on health care 
professionals and air crews, as well as on evidence from animal testing (IARC 
2010b). According to the overall results of epidemiological research, the risk of 
breast cancer can be increased 1.5-fold after 20–30 years of shift work. This 
evaluation is not epidemiologically very reliable because, so far, there are only a few 
results from only a couple of professions (nurses, air crews) and the risk estimates 
are only moderately elevated. The results are thus susceptible to bias and distortion 
(see Kolstad, 2008). In a comprehensive Swedish study, the risk of cancer had not 
increased among men and women working in shifts (Schwartzbaum et al., 2007). In 
a Finnish study, no association was noted between the risk of breast cancer among 
flight attendants and flying (Kojo et al., 2005). 
4.6.2 Other occupations or professions classified as carcinogenic 
by IARC  
Other exposure situations or occupations classified by IARC include, for example 
? Iron and steel foundry work, painting, rubber industry (Group 1) 
? Hairdressing (Group 2A) 
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? Occupational exposure in printing processes, firefighting, occupational 
exposure in dry cleaners (Group 2B). 
When it comes to occupations, it must be noted that the industrial processes and 
exposures in these occupations may have changed over the years, and these 
changes may have modified the associated risk of cancer. For example, the risk of 
bladder cancer detected in the rubber industry (IARC Group 1) was associated with 
the use of certain aromatic amines in the middle of the 20th century. After the ban on 
these substances, bladder cancer cases are no longer predicted.  
Epidemiological cohort studies have detected a consistently increased risk of lung 
cancer in iron and steel foundry work. In most of these studies, exposure has 
occurred before the 1980’s. In the NOCCA study, smelters and metal foundry 
workers had a slightly elevated risk of lung cancer (SIR 1.3, 95% CI 1.3–1.4). In the 
NOCCA study concerning Finland, a SIR 1.27 was detected for lung cancer  in steel 
and iron foundry workers (Pukkala et al., 2005), and the increased risk was believed 
to be primarily associated with exposure to quartz. The primary carcinogens in 
foundries are quartz and PAH compounds, as well as metal fumes [nickel and 
chromium (VI)]. 
Painters’ work has been found to be associated with an increased risk of lung cancer, 
mesothelioma, and bladder cancer (IARC 2010b). According to IARC, the risk of lung 
cancer cannot be completely explained by exposure to asbestos, although it is 
probably partly responsible for the increased risk of lung cancer (IARC 2010b). No 
individual factor behind the increased risk of lung or bladder cancer can be identified. 
Painters are exposed to several solvents and pigments, and some special paints may 
previously have contained also asbestos. The exposure has, however, changed much 
over the years; solvents and pigments have improved and solvent-free paints have 
become commoner. These changes have probably also affected the risk. In the 
Nordic NOCCA research project, a slightly elevated risk of lung cancer and 
mesothelioma was detected for painters (SIR 1.27 and 1.77), and a risk of bladder 
cancer was found for close to the background level (SIR 1.08). 
It is possible to be exposed to several carcinogens while working as a firefighter. In 
2007, IARC estimated the evidence on the carcinogenicity of firefighting to be limited 
for humans (IARC 2010b). The IARC review included 19 cohort studies, 11 case-
control studies, and 14 other studies with different set-ups. A recent meta-analysis 
(LeMasters et al., 2006) on 32 studies was included in the review. LeMasters noted 
that the risk of cancer had increased statistically significantly for 10 of 21 analysed 
types of cancer. Statistically significant risk ratios (RR) were slightly elevated, 
between 1.2 and 1.5 – with the exception of testicular cancer (RR 2.02). The results 
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were uniform in different research set-ups on prostate cancer, testicular cancers, and 
non-Hodgkin’s lymphoma, as well as multiple myeloma.  
Since the publication of Lemasters’ meta-analysis, two comprehensive studies have 
been reported (Ma et al., 2006; Bates 2007) that have been added to LeMasters’ 
meta-analysis material by the IARC working group. In this new analysis, the risk of 
three types of cancer was statistically significantly elevated: the occurrence of 
testicular cancer was increased by 50% (RR variation 1.2–2.5 in cohort studies); the 
risk of prostate cancer was elevated by 30% (RR 1.1–3.3), and the occurrence of 
non-Hodgkin’s lymphoma was increased by 20% (RR 0.9–2.0).  
In a new review carried out on Nordic material, a slight, general increase in cancer 
morbidity was detected for firefighters with respect to several types of cancer. 
Morbidity from prostate cancer was the highest in the age group of under 50 years, 
SIR 2.61 (95% CI, 1.35–4.56). For the group of over 70-year-olds, the morbidity 
was 2.61 (95% CI 1.29–4.80) for mesothelioma and 1.9 (95% CI 1.35–2.65) for 
adenocarcinoma of the lung (Demers et al., 2011).  
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5 WORKING GROUP RECOMMENDATIONS 
The Working Group’s recommendations for the compensation of certain cancers as 
occupational diseases in relation to different exposures are presented in Section 6.1, 
and the recommendations for cancer screening, the evaluation of exposure, and the 
standardisation of diagnostics can be found in Section 6.2.  
5.1 Recommendations for the compensation of 
occupational cancers 
The list of elements and compounds listed in this section is not exhaustive. They 
have been selected on the basis of existing research data on their carcinogenicity and 
because employees are exposed to them in Finland. These exposures have been 
classified by IARC as primarily belonging to Group 1 according to their carcinogenicity 
or to the EU category of 1A. There are, however, some exposures that belong to 
IARC Group 2A or EU Category 1B, as well as some with few data on their current 
carcinogenicity, for example, nanoparticles. These exposures have been included 
either because they are important in Finnish worklife or because they have lately 
caused widespread concern for their possible carcinogenicity, as is the case, for 
example, with carbon nanotubes. These recommendations reflect current knowledge 
about the carcinogenicity of different exposures and related evidence. As knowledge 
is gained, the situation may change, and therefore the recommendations must 
always be reviewed in the light of current knowledge.  
Smoking does not prevent the evaluation of a possible occupational cancer. If 
nothing else is mentioned in relation to an exposure or cancer, the latency period of 
a compensated occupational cancer must be at least 10 years. The latency period is 
the time between the beginning of exposure and the diagnosis of cancer.  
In general, exposures and cancers can be divided into the following three groups: 
? Exposures with strong epidemiological evidence. With such exposures the 
main challenge is to define the minimum exposure criteria for a diagnosis of 
an occupational disease. Examples are mesothelioma among employees 
exposed to asbestos and lung cancer among silicosis patients. 
? Exposures associated with cancer in epidemiological studies and situations in 
which the risk ratio (RR) increases beyond 2. Such exposures may lead to a 
patient receiving compensation for an occupational disease after the 
consideration of individual circumstances. 
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? Exposures with evidence of carcinogenicity derived only from animal testing 
and/or with a weak or modest association with cancer in epidemiological 
studies (RR < 2). These exposures do not generally lead to compensation for 
an occupational cancer. 
5.1.1 Asbestos  
5.1.1.1 Mesothelioma 
The connection between asbestos exposure and malignant mesothelioma is 
indisputable. There is no clear dose-response relationship. Instead, malignant 
mesothelioma even appears with low exposure levels. All employees who are 
exposed to asbestos and develop malignant mesothelioma receive compensation for 
an occupational disease. The latency period should be at least 10 years. Smoking is 
not a factor in the formation of mesothelioma. 
5.1.1.2 Lung cancer 
The association between asbestos exposure and lung cancer is also indisputable. The 
dose-response relationship is linear. High exposure is considered to be related to a 
doubled risk of cancer. The limit for high exposure according to international 
recommendations is 25 fibre-years, as indicated in the work history of the patient 
(Table 4, in Section 5.1.2.1) or a sufficient number of asbestos fibres in lung tissue. 
When the number of asbestos fibres in lung tissue is estimated, the faster 
degradation of chrysotile fibres and their removal from the system must be taken 
into account. The exposure level is also indicated by the number of asbestos bodies 
(AB) in bronchial lavage fluid or lung tissues (optical microscope analysis). The 
latency period of lung cancer from the beginning of exposure to the time of the 
cancer diagnosis should be at least 10 years. Smoking and asbestos increase each 
other’s effect on the appearance of lung cancer. However, smoking does not affect 
the decision concerning occupational cancer.  
5.1.1.3 Lung cancer in asbestosis patients 
According to research data, the risk of lung cancer among asbestosis patients is two- 
to fivefold. If a lung cancer patient has been diagnosed with asbestosis, she or she 
can receive compensation for an occupational disease. The manifestation date is the 
manifestation date of the asbestosis.  
5.1.1.4 Laryngeal cancer 
The relationship between asbestos exposure and laryngeal cancer is indisputable. 
The risk ratio is linear and correlates with the risk level of lung cancer. High exposure 
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(25 fibre-years) is considered to be associated with a doubled risk of cancer, see 
Table 4 in Section 5.1.2.1. The latency period from the beginning of exposure to the 
time of the cancer diagnosis should be at least 10 years. Smoking does not affect the 
occupational cancer decision for compensation. Unlike lung cancer, the manifestation 
date of laryngeal cancer is not considered to be related to the manifestation date of 
asbestosis. 
5.1.1.5 Ovarian cancer 
IARC has decided that ovarian cancer can be related to asbestos exposure (IARC 
2012a). Increased morbidity to ovarian cancer has been reported for women 
exposed to high asbestos levels in their work, but the relation between asbestos 
exposure and ovarian cancer is considered uncertain in research data. Ovarian 
cancer can be recognised as an occupational disease after the consideration of 
individual circumstances. 
 
5.1.1.6 Other cancers 
Evidence on the asbestos aetiology of colon, throat, and stomach cancers is limited. 
On the basis on current knowledge, these cancers cannot be considered occupational 
among employees exposed to asbestos. 
5.1.2 Crystalline silica 
Crystalline silica (quartz, cristobalite, tridymite) are carcinogenic in humans. The 
group level risk of lung cancer is twofold among patients with silicosis (i.e., stone 
dust pneumoconiosis), but there is no epidemiological evidence concerning the risk of 
lung cancer among employees without silicosis (RR being 1).  
Silicosis indicates sufficient exposure to crystalline silica. Lung cancer diagnosed in an 
employee who has been radiologically or histologically diagnosed as having silicosis is 
recognised as an occupational disease. The manifestation date of the cancer is not 
considered to be the same as the manifestation date of the silicosis. On the basis of 
current knowledge, lung cancer in an employee without silicosis cannot be 
recognised as an occupational disease caused by exposure to quartz. 
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5.1.3 Other occupational exposures and situations causing 
exposure 
5.1.3.1 Carcinogenic metals and metal compounds 
Exposure to nickel compounds has been found to be associated with lung cancer. 
The existing knowledge on the dose-response relationships is, however, inadequate. 
According to current knowledge, when the cumulative exposure remains below 2 
mg/m3 x year (for example, 20 years at an exposure level of 0.1 mg/m3), the risk 
ratios are so low that the probability of occupational cancer is low. The evidence 
concerning the carcinogenic effects is the strongest for soluble nickel compounds, but 
also low-soluble nickel compounds are clearly carcinogenic. According to SCOEL, 
when a person is exposed to average concentrations of 0.01 mg/m3 or less, there is 
no risk of cancer.  
Lung cancer can be recognised as an occupational disease after the consideration of 
individual circumstances if the exposure levels have been high (cumulative exposure 
in excess of 2 mg/m3 x year). These levels apply to both soluble and low-soluble 
nickel compounds. No evidence exists on the carcinogenicity of metallic nickel. The 
minimum duration of exposure is 1 year, and the latency period should be at least 10 
years.  
Nickel refinement has been found to be associated with sinonasal carcinoma. A 
cumulative exposure level of 1 mg/m3 x year can be considered as a guideline for the 
exposure limit. The minimum duration of exposure is 6 months, and the latency 
period should be at least 10 years. 
Exposure to hexavalent chromium (chromium (VI)) has been identified as a cause 
of lung cancer. There is, however, little information about the dose–response 
relationships. An exposure level of 1 mg/m3 x year (e.g., 10 years to a concentration 
of 0.1 mg/m3) can be considered as a guideline for the limit of sufficient exposure in 
relation to lung cancer, since exposure to higher concentrations doubles the risk 
ratios. Lung cancer can be recognised as an occupational disease after the 
consideration of individual circumstances if the exposure levels have been high. The 
minimum duration of exposure is 1 year, and the latency period should be at least 10 
years. 
There is information suggesting a relation between exposure to chromates and 
sinonasal carcinoma, but the association is uncertain. There is no evidence on the 
carcinogenicity of metallic chromium or trivalent chromium. 
Although a connection between exposure to welding fumes and lung cancer has 
been found in several epidemiological studies, the risk ratios have been low or weak. 
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The risk is affected by both the material to be welded and the welding process used. 
Manual metal arc welding of stainless steel exposes employees to the highest levels 
of hexavalent chromium, and, therefore, the risk associated with it is probably the 
highest. Welding of aluminium or non-alloyed steel does not expose employees to 
carcinogenic chromium (VI) or nickel compounds. An occupational disease diagnosis 
may be appropriate after the consideration of individual circumstances if the lung 
cancer patient has been doing manual metal arc welding of stainless steel for most of 
his or her career without adequate protection. In such cases, exposure can be 
considered to be significant.  
There is evidence for a connection between cadmium compounds and lung cancer, 
but the risk ratios have been low. Therefore, employees exposed to cadmium can 
receive compensation for lung cancer as an occupational disease after the 
consideration of individual circumstances if the exposure levels have been high over 
a long period of time.  
Information about the carcinogenicity of cobalt compounds has primarily been 
gathered from animal testing. Because the epidemiological evidence is inadequate, 
cancer cannot be recognised as an occupational disease among employees exposed 
to cobalt compounds.  
An elevated risk of lung cancer has been found to be associated with exposure to 
hard metal, but the evidence is still limited. In research projects that have detected 
an increased risk of cancer, the risk ratios have been low or weak. Lung cancer 
among employees exposed to hard metal can be recognised as an occupational 
disease in individual cases only after the consideration of individual circumstances if 
the exposure levels have been high over a long period of time.  
There is evidence for an association between arsenic exposure and lung cancer. 
Lung cancer can be recognised as an occupational disease among exposed 
employees in individual cases and after the consideration of individual circumstances 
if the exposure levels have been high. An exposure level of 0.75 mg/m3 x year or 
more can be considered the guideline for the limit of sufficient exposure in relation to 
lung cancer. The minimum duration of exposure is 1 year, and the latency period 
should be at least 10 years. 
5.1.3.2 Mixtures containing polycyclic aromatic hydrocarbons, i.e., PAH 
compounds 
There is evidence of an association between PAH exposure and lung cancer, as well 
as with skin or lip cancer in different occupations. The strongest evidence of the risk 
of lung cancer has been detected in coal gasification, coke production, and aluminium 
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production. In recent studies, employees who had been exposed to creosote, with the 
exception of chimney sweeps, were found to have an increased risk of skin cancer. 
Exposure to UV radiation may have also affected the risk. If lung cancer is diagnosed 
and long-term exposure to PAH compounds in, for example, coal gasification, coke 
production, and aluminium production can be shown, lung cancer can be recognised as 
an occupational disease in individual cases and after the consideration of individual 
circumstances. Skin and lip cancers (excluding melanoma) can be recognised as 
occupational diseases after the consideration of individual circumstances if long-term 
exposure to creosote in wood impregnation can be demonstrated. 
Exposure to diesel exhaust fumes has been found to be associated with lung 
cancer. In epidemiological studies, the risk ratios have usually been low or weak, but 
they may become significant among the most-exposed employees, such as 
employees working in underground mines. An occupational disease diagnosis can be 
made in individual cases and after the consideration of individual circumstances if 
high, long-term exposure can be shown. 
5.1.3.3 Environmental tobacco smoke 
Exposure to environmental tobacco smoke has been found to be associated with 
lung cancer. In epidemiological studies, the risk ratios have been relatively low or 
weak. There are no special groups whose risk ratios would be higher. When the risk 
levels remain low, it is difficult to estimate the occupational nature of the disease. 
Therefore, environmental tobacco smoke is not considered a reason for 
compensating lung cancer as an occupational disease. 
5.1.3.4 Solvents 
The connection between exposure to benzene and acute myeloid leukaemia (AML) 
is well known. The exposure levels to benzene in Finland during the last 10–20 years 
have however been very low. Therefore, occupational cancers caused by benzene are 
no longer probable. However, if sufficient exposure (i.e., 40 ppm-years) during the 
last 10 years can be proven, cancer is compensated as an occupational disease. An 
occupational disease diagnosis is supported by the occurrence of the myelodysplastic 
syndrome preceding cancer, a defect in chromosome 5 or 7, and poor response to 
chemotherapy. 
In addition to benzene, only a few other solvents commonly used in Finland have 
been found to be carcinogenic. When it comes to styrene, tetrachloroethylene, 
chloroform, carbon tetrachloride, and methylene chloride, the evidence is 
based on animal testing, and there is either no epidemiological data or the data are 
insufficient. Because the epidemiological evidence is insufficient, cancer among 
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employees exposed to these substances is not eligible for compensation as an 
occupational disease.  
There is epidemiological evidence for an association between trichloroethylene and 
kidney cancer. The data on the dose-response relationship is, however, insufficient. 
Kidney cancer can be recognised as an occupational disease in individual cases after 
the consideration of individual circumstances if the employee has been exposed to 
high trichloroethylene concentrations in his or her inhaled air over several decades. 
5.1.3.5 Dusts and fibres 
For saw dust exposure, the risk ratios for sinonasal adenocarcinomas can be very 
high. The increased risk is especially associated with exposure to softwood saw dust. 
In the Nordic countries, exposure to saw dust is caused by mixed saw dust, and the 
exposure levels significant for the risk of adenocarcinoma are reached already in a 
few years. The minimum latency period from the beginning of exposure is considered 
to be at least 10 years. According to the EU, the maximum latency period since the 
exposure has ended is 20 years. Sinonasal adenocarcinoma among employees who 
have been greatly exposed to saw dust is recognised as an occupational disease. 
When it comes to saw dust exposure and squamous cell cancer, the data on their 
relationship is contradictory, and the risk ratios remain low. Sinonasal squamous cell 
cancer can be compensated as an occupational disease in individual cases after the 
consideration of individual circumstances if high, long-term exposure to saw dust can 
be shown. 
There is evidence of an association between nasal cavity cancer and exposure to saw 
dust, but the risk ratios are low. Nasal cavity cancer can be recognised as an 
occupational disease in individual cases after the consideration of individual 
circumstances if high, long-term exposure to saw dust can be proven. 
The problem with the association between leather dust and sinonasal carcinoma is 
that only a few studies have investigated leather dust concentrations and their 
relationship with morbidity. Exposure to leather dust has, however, a clear 
correlation with adenocarcinoma. Sinonasal adenocarcinoma caused by exposure to 
leather dust can be recognised as an occupational disease in individual cases after 
the consideration of individual circumstances if high, long-term exposure can be 
shown. 
Epidemiological evidence about the carcinogenicity of ceramic fibres is inadequate. 
Current information about the carcinogenicity and exposure to carbon nanotubes is 
also inadequate. Because the evidence is inadequate, cancer caused by these factors 
is not recognised as an occupational disease.  
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5.1.3.6 Other carcinogenic chemicals 
Exposure to formaldehyde causes a relatively low increase in the risk of nasal 
cavity cancer when the rarity of this tumour is taken into account. According to the 
EU, the risks are related to exposures that cause severe irritation. Nasal cavity 
cancer caused by exposure to formaldehyde can be recognised as an occupational 
disease in individual cases after the consideration of individual circumstances. So far, 
no clear connection between nasal and sinus cancer and exposure to formaldehyde 
has been found.  
In certain occupations, an association between leukaemia and formaldehyde 
exposure has been identified. Leukaemia can be recognised as an occupational 
disease in individual cases after the consideration of individual circumstances if high, 
long-term exposure can be demonstrated. 
Exposure to butadiene has been noted to increase the risk of leukaemia. 
Cumulative exposure to doses exceeding 185 ppm-years can be considered as the 
limit of high exposure. High exposure peaks also affect the formation of cancer. 
Leukaemia can be recognised as an occupational disease in individual cases after the 
consideration of individual circumstances if high, long-term exposure to butadiene 
can be proven.  
A connection between laryngeal cancer and exposure to (sulphuric) acid fumes 
has been noted in conditions in which exposure levels have been high. Laryngeal 
cancer can be recognised as an occupational disease in individual cases after the 
consideration of individual circumstances if high, long-term exposure can be shown.  
Because the epidemiological evidence for a connection between exposure to 
cytostatics or ethylene oxide is inadequate, cancer caused by these compounds is 
not recognised as an occupational disease.  
The probability of occupational cancers caused by aromatic amines is very low in 
Finland because their use was limited already 50 years ago. If, however, a clear, 
long-lasting exposure to the aforementioned aromatic amines can be shown, bladder 
cancer can be recognised as an occupational disease. 
If a patient is diagnosed with angiosarcoma of the liver and long-lasting occupational 
exposure to vinyl chloride can be demonstrated, the cancer can be recognised as 
an occupational disease. It should be noted, however, that the exposure levels in 
Finland have been so low for so long that the probability of this occupational disease 
occurring is low. 
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5.1.3.7 Physical factors 
Exposure to ionising radiation is known to cause cancer, and a connection with 
several types of cancer has been noted. In occupational exposure, the association 
has been found primarily with leukaemia, and, for health care, the association is with 
breast cancer. When it comes to the dose-response relationship for radiation, it is 
known that an average occupational exposure of 1000 mSv will double the risk of 
cancer. The dose threshold of occupational radiation is 20 mSv/year. The calculated 
risk of cancer at such an exposure level is 2 cancers in 10 years for every 1000 
exposed employees. In Finland, the exposure levels of air crews and radiology 
personnel have remained significantly lower during the last few decades (since the 
1970’s), at 1–2 mSv/year. It can therefore be said that occupational cancer among 
employees who have been exposed to radiation after the 1070’s is improbable. 
However, among operating radiologists, the average dose during 5 years may 
sometimes locally exceed 20 mSv/year, a level which may cause a risk of skin 
cancer. These individual cases can be compensated as an occupational disease after 
the consideration of individual circumstances. 
Radon is known to cause lung cancer. Living for 30 years in a radon concentration of 
approximately 700 Bq doubles the risk of lung cancer by the age of 75 years. 
Previously, employees at mine sites could undergo significant radon exposure, but 
improved ventilation technology has nowadays lowered the exposure levels. It is 
usually difficult to separate occupational exposure to radon from environmental 
exposure. Lung cancer can be recognised as an occupational disease in individual 
cases after the consideration of individual circumstances if primarily occupational 
exposure can be proven. 
Ultraviolet radiation is known to cause skin cancer: melanoma, squamous cell 
carcinoma, and basal cell carcinoma. In addition, an association with lip cancer and 
certain eye cancers has also been detected. In Nordic epidemiological studies, the 
risk of skin cancer was not elevated, and the risk of lip cancer was only slightly 
increased. Skin or lip cancer can be recognised as an occupational disease in 
individual cases after the consideration of individual circumstances if high exposure 
can be shown. 
The connection between electromagnetic fields and cancer is uncertain. Because 
the evidence is inadequate, cancer suspected to have been caused by 
electromagnetic fields is not recognised as an occupational disease. 
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5.1.3.8 Biological factors 
If an employee has been diagnosed as a hepatitis B or C carrier and has chronic 
active hepatitis caused by occupational exposure, a possible hepatocellular cancer of 
that patient is considered to be connected with the same exposure and is therefore 
recognised as an occupational disease. HIV infection is also associated with a 
propensity for different types of cancer. Especially Kaposi’s sarcoma is typical among 
HIV patients, but also other cancers such as lymphoma occur. If the HIV infection 
has been caused by occupational exposure, any cancer related to the HIV infection is 
recognised as an occupational disease. 
5.1.3.9 Shift work and other occupations classified as carcinogenic by IARC 
Shift work, which disturbs the normal circadian rhythm, is probably carcinogenic in 
humans. It increases the risk of breast cancer slightly after 20–30 years of such 
work. The additional risk caused by shift work disturbing the normal circadian rhythm 
is, however, so low that there is no probable cause for making an occupational 
disease diagnosis. 
When it comes to other occupations classified as causing a risk of cancer, the 
situation must be evaluated case by case, and the epidemiological evidence about 
the occupation in question and the exposures related to it (individual exposure and 
its severity in that occupation, type of cancer and latency period from the beginning 
of exposure to the diagnosis of disease) must be taken into account. 
5.2 Other recommendations of the working group 
5.2.1 Lung cancer screening among people exposed to asbestos  
According to a review published in June 2012, lung cancer screening using low-dose 
CT may be beneficial for certain exposed groups, but it is still unclear whether the 
screening may cause harm and whether the results can be expanded to other 
exposed groups (Bach et al., 2012). 
Especially smokers exposed to asbestos have a significant risk of lung cancer. The 
current obligatory 3-year follow-up using chest radiographs has no effect on lung 
cancer mortality. The follow-up of patients exposed to asbestos should be modified in 
such a way that those with a high risk of lung cancer would be checked annually or 
bi-annually with the use low-dose CT scanning.  
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5.2.2 Forming a specialist group for occupational cancer 
diagnostics 
The Working Group recommends that the Finnish Institute of Occupational Health 
form a multi-disciplinary group of specialists for evaluating suspected cases of 
occupational cancer. This group would follow the available scientific research, 
concentrating on occupational cancers and their aetiology. The purpose of this group 
would be to standardise and keep up-to-date with respect to the evaluation of cancer 
causes. Upon request, this group would provide an expert statement on whether an 
individual employee’s cancer fulfils the criteria set for an occupational disease.  
5.2.3 Standardisation of data collection regarding asbestos 
exposure  
The Working Group recommends uniform practices for investigating asbestos 
exposure. In order to determine exposure, screening methods using questionnaires 
in hospitals and other care facilities are recommended. If exposure is probable, but 
the level is unclear, exposure data should be specified through the use of structured 
interviews carried out by experts. These experts should be personnel from 
occupational health facilities, occupational medicine clinics, or pneumoconiosis expert 
groups. If necessary, the centralised national (telephone) interview service of the 
Finnish Institute of Occupational Health can be used.  
5.2.4 Using chest radiographs to define the manifestation date 
of asbestosis 
If the asbestosis diagnosis of a cancer patient has already been verified on the basis 
of regular chest radiographs and the manifestation date has been defined 
accordingly, no further action is required. If asbestosis is diagnosed at the same time 
as cancer, the manifestation date of the asbestosis should be based on the results of 
thin slice CT–HRCT (computer tomography–high-resolution computer tomography) 
scans or tissue sampling. This practice is necessary because the most-reliable 
asbestosis diagnosis is based on the results of HRCT scans. Only if HRCT scans or a 
tissue sample is unavailable, should the diagnosis be based on, and the 
manifestation date defined by, other types of CT scans or native chest radiographs. 
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The memorandum from the Occupational Cancer Working 
Group 2013 is meant to update the suggestions made in the 
Memorandum from the Occupational Cancer Working Group 
from 1988. Its aim is to give recommendations regarding the 
diagnosis and compensation of occupational cancers.
In addition to the recommendations regarding the compensa-
tion of occupational cancers, the working group also takes a 
stand on the screening of lung cancer caused by exposure to 
asbestos, the forming of a special group of experts for occu-
pational cancer diagnostics, the combining of gathered expo-
sure information on asbestos, and the use of X-ray imaging 
determining the occurrence date for asbestosis.
The memorandum is published by Finnish Institute of Occupa-
tional Health in cooperation with the Finnish Ministry of Social 
Affairs and Health (STM), the Finnish Federation of Accident 
Insurance Institutions (TVL), as well as medical experts from 
the Central Organisation of Finnish Trade Unions (SAK) and 
the Confederation of Finnish Industries (EK)
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